63 results on '"R Rennert"'
Search Results
2. Prevalence of diabetic and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities
- Author
-
H Appeltants, C Boesch, I Cromarty, D Carretta, S Romanov, U Windstetter, F Mibach, Jens Refsgaard, S Lebedev, F Proietti, M Y Tamimi, M C Gamboa, M Novikova, E Prada, K H Sim, E Messas, E Zherlitsyna, A Kalampalikis, N Nevolina, N Trocan, J Cohen, G Szto, R Gilabert Gómez, M Omelchenko, A Pinzani, D Goodwin, J Umaran Sánchez, Kim Fox, S H Dong, K Kronberg, E Castillo Lueña, T Ignatieva, S Joubert, C Macchi, S Lee, S Eidelman, F Alizon, S Chandra, M Akbar, D M Colquhoun, G Yanes Bowden, J de Juan Baguda, M Sebastian, C Wernham, K Miedema, R La Greca, C Morton, B S Jheeta, A C Tran, T Q Do, O Rodrigues, J Yan, S H Kim, R Jurgaitienė, Jean-Claude Tardif, R Baleón, D Hay, V Hennebelle, F Fazekas, R Davies, P Gratia, L Sorodoc, S Y Wu, C Martínez Sánchez, L Lopes Antunes, T H T Pham, I Suliman, M J Gómez Martinez, A Pernat, S H Hur, M Alanazy, L Zhabina, M Stanley, J Rogers, Y J Kim, S Geffroy, L K Andersen, S Coman, V Pedrosa del Moral, Y Garaud, J Krupicka, O Dzhkha, C Paul, M Jeżewska, B Mahler Mioto, V Abduvalieva, P Morra, L Kucheryava, C La Rosa, B Chan, M Wrębiak-Trznadel, A Kozlowski, M Sharif, L López Barreiro, V Kolesnikov, M Lawrence, A Tucker, C Okawabata, B La Hay, E Sadauskienė, B K Nguyen, L Bui, A Said, M E Ruíz Esparza, R K Saran, M S C Ho, E Homs Espinach, J R Romo Santana, J Forte De Carvalho, I Pattison, H H Phan, L Baleeva, L Kisiel, A López Granados, C Raters, F Paganelli, R Haberl, A P T Wong, D Xu, R Jagathesan, L Grekhova, H Stursova, Q B Truong, P Raymond, Y Sosnova, N H Khong, J Zarauza Navarro, C Florescu, L Gorshkova, N Saaidin, E Gordillo Higuero, L Davin, I Budanova, C Lavicka, L Gruznykh, P Bogdański, A Dufka, I Arroja, H A R Tahir, G Wilson, G Kolios, S J Yoon, Simon Cattan, K Berdnik, A Serrano, B Sievers, A Rodríguez Almodóvar, L A Holden, F O'Reilly, D Verleyen, H Hafez, K Nehrig, S M Kang, S Berrisch-Rahmel, E Meyer-Michael, P Samama, L Soares, A K Nguyen, F Tuktarova, C Weytjens, E Sandoval Rodriguez, J Cheng, F M Villasenor, João Morais, B Sullivan, R Zimoląg, Albert V. Smith, S F Ding, J C Louchart, G Guardigli, R Furtak, P Azzolini, S Chushak, J L Delgado Prieto, S Kornienko, K K Sia, J H Shin, F Baylac Domengetroy, P Błaszczak, M Saade, N Černič-Šuligoj, K Coetzee, A Kadleckova, V Scollo, O Larina, R Pal, M M Singh, N Nosova, R Burns, B S Yoo, O Gukov, F Massari, V Antia, A Brattström, G Holt, M Scherbak, V Firastrau, Y J Li, E Mikhailova, L Machado Cesar, C García García, J Pjontek, C Everton Biglow, G Pes, C Brown, A Bumbu, S Felis, R Bosch, M Lazaro, Luigi Tavazzi, R Engel, I Romeo Castillejo, Y S Byun, F Matias, I Grushetskaya, C Mestre-Fernandes, T Kheliya, S Schlesingerova, G Theodorakis, I Tsamopoulos, R Pedretti, A Puente Barragán, M P Vo, B Lammens, T Carruthers, J S Bhatt, A Khodanov, N Pasechnaya, I Petrova, G Boutros, I A Khan, E Le Moal, D Garofalo, H R Malaterre, A Bahal, J F Martínez González, H N Dinh, N V Pham, C Barjhoux, I Gilmour, C Soriano Navarro, O D Chioncel, K Tóth, N Borodina, P Khanoyan, B Sevilla Toral, H H Kim, C M A Bui, C Dernedde, N Eliseeva, M Galinier, E Kosachek, M M Doohan, L Potapska, M Tennekoon, R Nourallah, L Perez De Isla, K H Chee, E Panova, D M Walker, G Glanowska, G Hua, A Silvestre, W Wang, Matthew A. Brown, B Luke, G Jarosiński, R Davis, S Cleron, C Liatas, I Orestis, M Dereń, J Sudnik, S X Zhou, J Fuertes Alonso, O Baranova, S Mingalaeva, T N Vo, K A Ngo, J A Rodríguez Fernández, R Ishmael, G Bode, K K Chan, G Al Radaideh, S Ramphall, H D Theron, V Montagud Saavedra, A Yusuf, G F Mazzanti Mignaqui, L Evtukhova, J Lorenc, D Beacock, O B Šlapikienė, F Alitto, J N Poujois, B Berzal Martín, M Felbermayer, V Mallamaci, T Spitsina, R Ramachandran, A Jánosi, V Dženkevičiūtė, S Gillam, V Joulie, G Esna Ashari, R Henry, E Durand, A Alam, V Fourchard, H Dreycopp, R Fressonnet, C Camossa, O Jerzykowska, M Castrucci, G Sinicropi, B K Goyal, V Vasylenko, R Grogono, M Partington, B Vaquette, R Blindt, Mª T Moreno Casquete, V Kukaleva, W Streb, P F Clavette, M Pérez Paredes, V Hadjiivanov, C Bundy, D E Manyari, A Wassef, J Kuchar, W Nisker, P S Bath, S Panpunnung, G H Choo, Datshana P Naidoo, Y Pavlova, R McManus, N Brand, E Davies, L Prunier, A Schenowitz, P Sternthal, T Sinotova, J Martínez Florez, R Sykulski, J Pinar Sopena, M Balbi, Y Pesant, D A Playford, C Villar Mariscal, F Redding Escalante, W Wongcharoen, O Grechishkina, A Girão, M Speth-Nitschke, K A Mahendran, A Bianco, A Vadavi, G Singh, L Petoin Peuch, L Sukhanova, A Y Y Fong, J L Vega Barbado, A Dzien, S Honorat, G Ansalone, G Kamensky, G McLaren, T B Kim, I Bratu, R Fillet, V Rogozhyna, L Nagy, M Malgina, M A Sheikh Abdul Kader, Z C Li, L Rotaru H Rus, D Adamczyk-Kot, J Estrella, S Serrano García, P Farto E Abreu, D Mescharekova, Su Thillai Vallal, P Seal, S Möller, A Cziráki, T T H Ta, S Davies, H Ge, M Arafah, M Ovize, A Olszewski, V Aboyans, C Roche, F Al Tamimi, L Popova, V Kazachkova, R Rennert, J Aubry, G Bourgeois, J Mackrell, F Al Kandari, N Reifart, J Bérubé, W H J Hutse, O Lysunets, I Butkuvienė, J Cotroneo, J Gdalia, J Dalle Mule, R Santos, B Singh, H Mohammed, A Birkenhagen, T Chiscaneanu, H Sullivan, Jacob A. Udell, N Bolotova, A Jankowska, M Skonieczny, B S K Ch'ng, O Aiyegbayo, S Ciaroni, N Lago, S R Coimbra, R Ellis, B K Koo, S Rostik, P Jacquier, A Conradie, N Biryukova, M Ayche, A Khripun, B Peperstraete, E Velasco Espejo-Saavedra, G Cunliffe, G Grollier, C Ceraulo, T L To, Q H Tran, M Anscombe, R Jordan, I Czuriga, P Haimes, R Ancín Viguiristi, H Q Zhang, C A Chételat, A Rafter, E Rinkūnienė, K Yang, W Gao, J Pearce, L C Fernández Léoz, L Gareeva, R Fernández Alvarez, G Verret, P Astrakhantseva, C M Chu, L Murphy, P A Do, J L Liu, A Clifford, K Woollard, N Dmitrieva, N Lousada, R Díaz Juárez, N Semenova, T Fesenko, F Henschel, R Amini, G Matuszewska, R Christodorescu, J Varaldi, S Varughese, V Lafarenko, A Ashford, J L Colomer Martín, S Assouline, H Noor Hasni, A Weatherup, T Forster, R Kaserbacher, I Caldwell, N Arabadzhi, Emmanuel Sorbets, A Rink, E C Rueda Calle, J M Stordeur, P West, V C Do, Béla Merkely, J Antunes, U Altmann, S Magheru, B Bachmann, W Parkar, M de los Reyes López, M Wazana, A Frattola, M Mospan, V Koval, E Giusti Rossi, J Vasconcelos, K B Do, A Ogorodnichuk, D Lighezan, G Mentz, J M Cherry, P Pouderou, M Moretti, C M Spinu, Emmanuelle Vidal-Petiot, N Kupstytė, P Jourdain, V Voronina, O Varezhnikova, S Williams, H AlFaleh, R Lew, P Hildebrant, J Drozd, G Muscio, T H Ashton, A Achilli, J Harinasuta, T Ghose, G Walawski, Y Arkhipova, M Alves Costa, B Day, A Suntinger, A Singh, P Sheringham, A Vázquez García, J Taggeselle, J T Dong, T H Goh, G Rojas, R Schultz, A Ballet, O Likhobabina, Z M Qian, S Sandoval Navarrete, D Manzi, S Langridge, W Haerer, C K Abdullah, L Hay, Á Herdade, A Gałuszka-Bilińska, F Biausque, V M Lai, D S Eccleston, L Nikolaeva, P Kalaras, J Martínez Redding, N P H Tran, B Wauer, Philippe Gabriel Steg, B Etcheverry, J Navarro Manchón, R Augarde, C Dixon, M Y Chen, J L Gleizes, S Pustovit, J L Farges, S Cox, G Manchet, K Shein, L Parker, C C Ang, O Sinyukova, V Veth, A Kurekhyan, N Cindea Nica, N Wittlich, J Al Yazeedi, A Pucheu, V Elliott, J Bories, K Alford, M F Ferrão E Vasconcelos, A Adamkiewicz-Piejko, R Cervenak, J F Beltrame, A Castro, L Safonova, G Koutsimpanis, C de Brito Vianna, R Wysocki, V Ginzburg, J Hernández Afonso, A Ihonor, O Golubeva, M Karachaliou, S Kleta, D d'Este, Gustavs Latkovskis, F Jäger, E Gamzatov, Y Kozhelenko, J Lippai, T T L Ong, S J Ge, A Hersi, K Kyd, S Mingam, V Yordanova, L Bardachenko, E Mozerova, S W Liu, J Zdrojewska, E Chung, M Leclair, M Nazir, S Zarechnova, A Rahman, M Sołtysiak, B Maguire, F Moreira Pinto, R Fathi, E Prieto Moriche, C Priftis, P Heno, N Sytilina, A Pladys, S Shimonenko, P Keller, J F Junior, G Amiel Oster Sauvinet, J P Kanner, L Tkachenko, J Dalal, A Liston, D Herrera Fernández, J L Bonnet, A Chirivella González, R P Shah, F A Reyes Cisneros, C Avgerinos, P Ravoala, V Albero Martínez, G Suarez, V Jouve, A Frankiewicz, A Lindsay, A De Meester, H Dau, M Pornin, J Álvarez Gil, J Murin, T Hodac, J J Gómez Barrado, Y J Wu, S Jean, P Hilti, A Dayani, R Steponėnienė, G A Somsen, H Zhang, J Moore, P Tarenidis, T H Nguyen, M Maliszewski, L Voloshyna, S Novo, A Phrommintikul, I Shanina, Roberto Ferrari, P Franklin, C Turner, W Boonyapisit, F Sepulcri, P Vandergoten, J Carvalho, J Halcox, V Rotenberger, J F Baril, M Turiel, P Shiels, P Painsipp, S Reis Monteiro, T Honsig, V Vivekaphirat, J Ardill, P Brodzicki, A Khalifa, H Audibert, T Wettstein, F Auhser, D Ezekiel, D Pella, E Simarro Martín-Ambrioso, H S Seo, J A Núñez Gamero, Gabriel Steg, M Orbán, S Bykovskaya, W Gadziński, N Rozkova, G H M Vawda, R A Motyer, B Limeres González, E Fernandez Valadez, Riyaz S. Patel, I Shaikh, E Ziak, A Estriga, P Dodemant, Dragos Vinereanu, W Miao, L Marullo, F MacNamara, S K Tan, N Giacomantonio, A Leherissier, H W Li, Arpana Agrawal, Y Moreau, F David, S K Ma, A N Jamaluddin, E Alegría Ezquerra, Scalzo, M C Ta, T T Nguyen, A Sudre, R Gupta, H Lagioia, M Haiba, P Kohan, M Szentivanyi, T Dmitrieva, N Vechtomova, C Vuille, R G Schena, P Navratil, O Tsygankov, L Saaby, P Lefebvre, S King Wong, S Maheas Morlet, N H Pham, P Bonnet, S Modi, L Gaspar, M Karlicek, S Pallie, H T Pham, S Abele, N Bizyaeva, L Facila Rubio, N Meneveau, G Poluyanova, J Calaça, S Orazi, M Emonts, A Yusufali, V Sprott, Z Vazhdaeva, M R Conte, E Bulakhova, K Giokoglu, E Page, E Kotova, G Maragoni, C Jerjes Sánchez, T Kiver, M Brunehaut Petaut, A Nagy, P Singer, Zs Sziegl, B Fontanet, S Strange, A Watson, J Föchterle, Janet A. Dunn, R Šlapikas, M Stikhurova, S Salimova, J Volmar, E Otero Chulian, S Hutchinson, R Koller, X Bonnaud, E Peris Domingo, F Marín Ortuño, E Galve Basilio, S Bongo, L Payot, C Miller, A Samothrakitis, L Silva Melchor, K Orzechowski, W Hofer, L V Nguyen, R Oliver, K T Jung, J Robb, D Sobczyk, J Muller, A Tomatti, M Gruchała, C Bradshaw, D Richmond, E Mineeva, E Smirnova, A Idrissi-Sbai, H Vial, R Balai, I Kiseleva, H Jones, M Gibbs, D Ohlmeyer, Y Al Wahshi, V d’Alessandro, S Pérez Ibiricu, V Zachos, A Chernozemova, D R Spink, J Schneider, A M Peset Cubero, M Irurita Latasa, M Migliore, G Perna, E Daniels, M H Tay, N Z Khiew, I Soin, F Bernasconi, T Garban, F Omardeen, O Rodina, L Kanagaratnam, I Blum-Decary, A Jaussi, D Romero Alvira, D Vermander, N Kanumilli, M A Romero Maldonado, M Fernández-Valls Gómez, H Tran, T P Nguyen, H Omar, R S Collette, B Kisjós, H Krause-Allmendinger, J Silva E Sá, H Topf, F Panetta, T C Do, G Roul, J Leso, A Lacroix, M Fic, C Hart, R Chan, L Lema, Y Polyanskaya, R Howlett, Lesley J. Burgess, X P Chen, Hywel C Williams, V T Le, N Gurianova, R Duchowska, V P Nair, D Mitropoulos, A Allcock, T T H Bui, M Golub, E Yakovenko, M Perry, F Belcastro, K Svolis, B H R Forge, F Fernández de la Cigoña, N Murga Eizagaechevarría, G Mariano Pêgo, V Mincheva, T N Nguyen, J Moyal, M Wei, H Vinhas, A Batalla Celorio, C Romero Menor, S Rahman, N Hassler jun, F Duclos, K Ladha, A Ordóñez España, B C Chang, R Cortés Sánchez, G Lafrance, I Mihailova, Y Riou, I Pashentseva, S Tantillo, U Casas Juarezy, Ian B. Wilkinson, MJuneja, Q L Liu, M Baquero Alonso, P Kirmond, A Stevens, T Bouvy, P Casas Giménez, G Kassianos, P Kohler, T Rundell, J A Romero Hinojosa, T Sagastagoitia Gorostiza, M A Bennouna, A Hourany, F Thoin, G Steurer, V Batushkin, L Kolevatova, A Földi, G Sabe-Affaki, J T M Geraedts, I Illushechkin, T Korotich, W Manlay, B Merian, G Morrison, Y Wang, G Solache, P Magnus, A Lugin, S Tereshko, Jorge Escobedo, D Sharp, A Thelemann, J Gold, M Catarino Carvalho, P Lang, B Hermellin, B Doucet, A Martín Santana, E Foltzer, J Mora Robles, A I Bakbak, G Stanciulescu, L Baurenski, O Demina, G Lalljie, N Shmakova, R Vicente Amato, N Q Nguyen, S Kimmel, J-M Grégoire, F Tumarov, R Cue Carpio, S Nikishina, A Mukhtar, J Rueda Soriano, M Gnädinger, Michal Tendera, P Raska, S Cicek-Hartvig, E Potapova, A Melero Pita, P Ormiston, L Pastor Torres, R Shaw, M S Chenniappan, T Guo, L Zharikova, R Amoretti, J Janssen, G Kositsina, S Rajendran, N Atamanchuk, V Plastiras, T Kiernan, M H Pham, V M J Jelinek, J Dalrymple, S Van de Walle, M Goethals, I Stelmakh, S Cantabrana Miguel, L Hurlock-Clarke, C Ferreyra Solorio, J Alcaravela, H H Chuang, C Statescu, T Ługowski, B G Vanhauwaert, E London, G Z Pan, Z Özkan-Rashed, F Fellous, O Fillipova, K Ashmak, L Sargento, N Starostina, J A Ortiz de Murua López, H Thomas, T Gerasimova, L H Gowdak, S Perings, E Gaxiola, K Walcher, O Pogrebna, T Stasiuk, J Bell P McNaught, J Upton, G Scott, P Rossi Sevillano, A Gillet, T K L Nguyen, L E Manautou, L Kardashevskaya, A B Syed, F Brumelot, E Il'ina, V Alekseenko, G Wehr, G Gerges, B Fitzgerald, M Castellari, I Bratishko, M Dorobantu, I O'Connor, M V Ivan, A Esenokova, M Z Abdul Wahab, S Sylivris, S S S Quek, P Buffet, L Thomas, S Darnes Soler, N Pelicano, B Truong, N Vyshnevaya, M Habab, J Moreira, S Z Lv, D Shukla, P Eavis, E Kryvenkova, S Hansone, S Tabet, M Adda, R Trambitas, L A Fernández Lázaro, M Basara, R Mažutavičius, B Roy, X Dreyfus, T Karaseva, R Tilluckdharry, K Królicka, A Rogowsky, A Rodríguez Fernández, S Junejo, H Ancliff, W K Son, G Bodur, G Pournaras, N Sharapova, J Egido, S Kuanprasert, E Alexanderson, L Vanneste, L Singh, N Bokuchava, D K Jin, E H M Tan, A Bernard, F Baslaib, M A Fazil, M Deissner, F Narro García, R Bonhomme, A Dan, V S Hoang, R Snikytė, O Ratovskaya, T T N Pham, M I Mendonça, F Bates, N Karnaukhova, P Nazeyrollas, L A Elizondo Sifuentes, D Onger, S Yakovova, R Sadłowski, B Doronzo, J Carda, A Taylor, A Albuquerque, V López Mouriño, I Segura Laborda, D O'Donnell, R K Pandey, M Asplanato, M A Paz Bermejo, E Rodríguez, L C Iosipescu, K Fikker, Y Porras Ramos, M Escande, D Binet, J Mantoux, P Barahona Pérez, V Zakirova, A Rocha de Lorenzo, I Konstantinidis, H-H Breuer, B Hockings, A Muthu, Koon-Hou Mak, A Soward, D D Ionescu, P Talbot, F Patriarchi, A Meinel, S Abdel Malak, E Craiu, N Ranjith, B A Lim, R Rosado Soares, G Barauskienė, J Vercammen, N Shelomova, S Govender, S González Romero, K S Ng, D M'Bey, B Al-Khalidi, J Berlingieri, J B Fournier, J Tan, P Mochkina, S Pouwels, G Caridi, D P Phan, P Soskin, D Farcas, C Constance, D Rouse, A Tudose, J M Yu, T T C Nguyen, R Brownlie, J Giordano, A Gigantino, T Yip, A I Noury, R Baroudi, E Pinch, I Landragin, T Cahill, N H Mohd Amin, S Baptista, V Lavicka, P Rodenas, M Jeserich, K F Alhabib, U Teleky, M Ege, D Bierge Valero, D Kozlov, M Vallis, A Rahali, F Maes, E Guiu, P Hutayanon, C Escobar Cervantes, H D Luong, T Salah, J C Ford, C Travill, G Barron, L Rebelo, A S Abdullah, K-H Schermaul, Z Lorenc, F Perreault, O Shamsutdinova, A Fernandes, H Rickli, E Usoltseva, C Cazenave, N Baboshina, P Matthews, N Schön, W Matta, J H Zo, N Pontaga, E Novo García, G R Searles, J A Wang, M S Grocutt, A Kondratovica, P Povolna, J Arnedillo Pardo, J L Prevot, J A Rodríguez Hernández, H Killat, M Hinrichsen, S Santaolalla Rodríguez, F Calvo Iglesias, P Mpompoth, M Claus, K Kunhali, K Panisois, A Lourenço, D Iovescu, I Simkova, C González Juanatey, A Vicentini, C Baranes, J Hilario Jiménez Orozco, M Magherusan, I Orpen, M Horrigan, M Banu, R Weinrich, C Arsenescu Georgescu, R Dubinskaya, Y Kulikova, C Petrillo Pio, N Khishova, R Mika, P Dalampyras, M Maćków, M H Custódio, M A Cobos Gil, Y D Chen, B Bondarenko, V Puel, S Garg, Y Lemiere, J Bruguera Cortada, A Pereira, C Vaticón Herreros, V Ravlyk, G Pons, E Osadchuk, Dayasagar Rao, O Charikova, E Liu, M Baverstock, V Kulygina, J P Dubs, V Climent Payá, M Grobéty, I Krajnc, I Feldmann, A Idoate Gastearena, F Paillard, M Alanbaei, D Sinclair, F Pitella, M Casanovas Pié, R Sheahan, F J Nasser-Sharif, M Goralski, D Kinloch, N Chauhan, M Sandin Rollán, M Didier, N S Pham, W Heddle, N Oleinikova, E Verbrugge, C Amo Fernández, M Kraus, Y K Chan, A M Kushner, K Phillips, V Barriales Alvarez, V Martins, P Talavera Calle, Y Jobic, P Túri, C Greco, G Scalia, J Flores, P Saul, C K Wong, O O'Toole, S Nurgalieva, K Makarenkova, S Hayne, S Kutuzova, N MacCarthy, D Logan, J M Dubois, J Cygler, M Kindel, V Karnot, T Herbots, G Masszi, J de Jesús Rivera Arellano, C Botana Penas, T Vicente Vera, R Karnik, J Morales González, L Lasalle, A S Sahar, R Forrai, A Shekhar Pandey, T Wang, N Maximchuk, A Chung, D Zalewska, O Bashkirtcev, A O'Gara, E Dubinina, H E Harlos, P Meyssonnier, G Dalton, X Tabone, R Capalneanu, I Soosiwala, J Finlayson, H Soleille, T J Hong, I Myhailiv, K Babes, K Modzelewska, Robin Young, K Mayr, J Freire Corzo, J M Bourgeois, S Guerard, F Fernandes, A Loera Pinales, C Schmied, A Minsafina, J Ingham, J Escobedo de la Peña, Y Guo, C Krasucki, R Gendreau, J Bonal, I T Ly, M Jaquet Herter, W Kępa, B Prasad, J L Zamorano Gómez, S Banham, P Ziehn, Nicolas Danchin, C W Goh, M Gonzalvez Ortega, D Dymova, P Bishop, T Dutoya, J E Poulard, P Monnier, O Si, J L Briseño, G Attia, N Khartova, I Gorlova, L Raisova, B Faudon, V Freeman, M Kerbev, U Frank, G Kaliska, A K Ghapar, C Tricot, L Jankowska, V Dormagen, A Pasquet, I Kruglova, P Chemin, J L Díaz Díaz, J H Tao, R Bietzk, G Sceats, K Lai, P Berthezene, Digna R. Velez Edwards, A Buakhamsri, N Bazargani, U Spengler, M Toringhibel, M A Matos, I Skoczylas, V Arrarte Esteban, J Fuertes Beneitez, V Gil, L U P Tran, A Mehta, A Álvarez Sangabriel, P Di Pasquale, K Egstrup, P Choudhury, S Whetstone, T S Chee, M Elkohen, P Martina, J Martínez Rivero, C Arden, J Walczewska, I Benett, R Silvestri, V García Saavedra, J Słaboszewska, A Thomson, S Revienė, A Szpak, V Challenor, F Saporito, P Ruiz Pérez, Vives, H M Li, I Sadykova, D Lawton, T Kuzmina, R Elias, D Troup, P Dehayes, J Vavougios, V Pernice, P Tanielian, R Cabrera Solé, T Pitsch, R Nethononda, P Poinson, A Tavares E Taveira, J Yi-MingCha, J Y Hwang, T Haghfelt, C García Pindado, N Bilous, A Kotsalos, M Bariaud, A Drzewiecka, L Polkina, V Arfaras, P Vymetal, J Rawal, A Aumjaud, H P Wang, L Wu Amen, J Fernandes, F Howie, A Ouguoujil, M H Ngo, J A Bertarini, A Malysheva, G De Geeter, N Aimouch, R Parkin, H Taylor, M Kittipovanonth, A Gupte, S Ramanaidu, L Basto, A Zherebtsova, T Arsentieva, V Männl, Y L Cham, J J Gómez Doblas, D Ennouchi, Iveta Mintale, A Vance, R Jirmar, L Boikova, D T Le, P Srivastava, L Tonet, M Liautard, C Proto, Q H Do, Mª A Pérez Martínez, R Stankevičius, L Semedo, M Anghel, I Nikolaeva, J Janes, H Al-Backer, M C Escourrou Berdou, O Leshchuk, D Reshotko, V P Dang, I Édes, L Schlueter, B Sikorska-Buczkowska, K Hatalova, I Marozsán, S Gessner, J Gmehling, M Kuzmicheva, Z Huang, L Kosareva, D K Kumbla, A Baika, F El-Shaer, T Voronova, J M Chopo Alcubilla, A Veternik, S Mohr, D Garcia, J Y Rhew, C K Yeo, C De Niel, H K N Nguyen, E Orts Soler, J Dubrava, S Natarajan, M S H Khan, U Kossowska, J P Detienne, T T H Nguyen, I Centa, M G Millauer, Jose Lopez-Sendon, J T Counsell, E Galehr, T Schröder, L Frost, P P Singh, C Moya López, R Beyer, L Carpentier, J Carrillo Calvillo, Z M Du, R Steeds, E Horstkotte, P Kindler, P Johnson, M Sander, I Rodríguez Tejero, F Azar Manzur, S Brown, M Odín de los Ríos Ibarra, C K Choor, M A Sadiq, D B Gysan, V B Doan, A Gueusquin, M Andrews, L L Feng, B Martina-Hooi, S R Shetty, Y Dascotte, E T Ch'ng, P Dematteo, A Woodall, S Gabriilidis, Jean Ferrières, S K Oh, J Lindford, S Blignaut, L Macedo, R Carrillo Cardoso, Y C Lai, C Lang, S R Jayasinghe, B Bastian, V Sanfins, J de Jeús Zuñiga, F X Meriaux, G Sepp, S Molotyagina, S García Ortego, T Perger, Y Lukina, J H Wirtz, A Regulska, P Durand, P Loheac, J Sinnadurai, S Avlonitis, J García-Moll Marimón, J Bradley, K Pareathumby, L Latyntseva, D Stergiou, K Ling, S K Hong, N S Chonkar, C Goldie, C C Koo, A Salustri, Y Peneva, I Rodríguez Briones, P Ferreira, L Franskyavichene, G Bragança, C Rodrigues, S H Lee, L Dang, B J Lubelsky, L Weinrich, E Hoffer, J Tricoire, M Marachli, O Smirnova, C Falces Salvador, A Mobeirek, M Fagan, A Serazhim, M M W Yeung, F Petitjean, I Cullen, J Benacka, Yañez Wonenburger, D Gentille Lorente, J Ferreira Dos Santos, F Bosa Ojeda, N Marchionni, L Brottier, P Keelan, D Kerö, L Moretti, R Seabra Gomes, I Jasinkevica, P Purnode, D Relange, H N Luqman, A Petit, I Hamilton-Craig, E Kochurov, P Berry, P Aguar Carrascosa, M Noble, S Yvorra, N Razzaq, J M Walch, L Lenartowska, R Sethi, W Kim, C Killeen, S Kurochkina, N Capuano, P Sampson, K H Mak, T Bouchaya, J Hellermann, M Geneves, F Ramos Ariznabarreta, J L Mougeolle, J Ferreira, T Roy, J de Andrés Novales, J F Monteiro Ferreira, M S Mayer, N Lopez Cabanillas, P Touzet, K H Ng, F Pelier, T K Huynh, J Schindler, T Krechunova, A Gaglione, Z Fras, P Haralambus, R Pradhan, L P Low, G Odent, M Sidor, R Sopia, D Janody, T K Ong, K Adamaszek, G Vives Boniato, T Maxwell, H Charles, D Gough, O Dibon, A A Abdul Rahim, H B Liew, S Tikhonova, I Bläse, J Chambel De Aguiar, E Santas Olmeda, M Rosseel, R Angela, D Savard, C Cernetti, O Huttin, J Calder, O Kilaberiya, A Elkrail, I I Tulevski, A Ilyukhina, E Chalkiadakis, R Antonicelli, H C Gwon, G Bautista López, G Brown, J Kojelienė, R Zeitouni, J Mimoso, N Better, N H Vu, H Abdel Wahab, B Poprawa, F Weber, A Ghicu, K Rybak, G Fouquet, C Pindado Rodríguez, A Salakhova, L Isaeva, M H Fallacher, J Placke, G McCansh, V D Tran, O Gusev, D Enayat, P Khera, E Brice, G Levesque, A Alvarez Auñon, M A Arnau, M A López Aranda, E Andreicheva, I Kruck, R Grigoriu, I Sainz Hidalgo, M Węglarz, A Ajani, I Khudina, T Makhieva, V D Dang, R Testa, E Cisowska-Drozd, F Giacomazzi, R Cierpka, Nicola Greenlaw, P Wong, L Simões, L Tsaryabina, O Gureeva, R Raffelsberger, H Luquez, A Rainbird, D Evéquoz, M A Balice-Pasquinelli, R Massay, K L Joseph, I H Chae, R Herrmann, I Salecker, A Montero Gaspar, P F Fonseca, A Martin, W Czarnecki, R Motomancea, E Dechoux, M Shamsuzzaman, M Leandri, D Marzal Martín, C Navas Navas, C Beaurain, T Gkinis, K Shetty, P A Jeannerat, D S Wong, A Gonzaga, W Kulig, J F Millet, E Jankauskienė, E Anastasiou, A I Ruhani, N Aksyutina, O Kolesova, K Yared, M Panajatovic, Y L Zhou, S Thurston, T Alekseeva, S Preston, N Mai, M Kuzyakina, D Rechtman, T Boonyasirinant, J Nobre Dos santos, A Ahuad Guerrero, M Al-Shamiri, M Feldner-Busztin, S Godart, S Liandrat, A Narayan, L Burlakova, M J García Martínez, C Militaru, J Chávez Paez, H B Matheson, D Meddah, P Brindle, N Petrova, A Nicolino, D Spensieri, A Giuca, E Molina Laborda, J Moreno Arribas, V Martinho, T Mularek-Kubzdela, S K Chua, G A Dan, N T H Tu, V T Nguyen, M Alcocer Gamba, J Costa, H Milligan, R Badr-Eslam, E Variava, A Merkhi, C Mays, R De Castro Aritmendiz, A K Mohamed Yusof, A Hamer, R McNeilly, S Dedkova, D Rousson, K Chamou, A Mahr, D C Dan, R Till, T L Yang, M Vida Gutiérrez, D Piyayotai, É Bajcsi, D Zaronskienė, I Alexopoulos, Y Huo, H S Zeng, P Rowe, S Fleming, D B Vu, Á Dongó, C Hand, J C S Leong, M Claeys, S Hood, J Bozkova, G Vieyra, G Unger, A Liqui-Lung, D Cremer Luengo, M Castillo Orive, S Muth, M Joseph, P L Torres Díaz, C Zakopoulos, D Cross, F Trujillo Berraquero, F Sattar, H A Boyrazian, T B Le, M Mantcheva, M Constantinescu, P Gosse, U Keil, G F Vaz, M Bdeir, T S Pham, M J García González, J K Ryu, D W Jeon, Zs Malkócs, J Á Perea Egido, R Izquierdo González, V Probst, E Wellenkamp, C Boureux, M Czarnecka, C Vaughan, H Falconer, H Brunner, G Peña Pérez, E Nelböck-Huber, E Blanc, F Thomas-Richard, A L R Ng, M Provvidenza, R Gascueña Rubia, J Freitas, A Dabboura, B Mörz-Proszowski, A Utech, C Alves, C M David, J A Lastra Galán, L Oliveira, T A Nguyen, I Ghaly, A Hofmeister, I Gorodilova, P Szałkowski, M S Hiremath, G Golovina, C Daly, M Tardy, S Kostomarova, J-P Salembier, P Zagožen, D Wang, M Vogel, J Borbola, I Chlewicka, K-H Schmitz, C Pappas, J Victory, M Garandeau, P Wiggers, C Piñero Ramírez, L Tkhorzhevskaya, E Suglobova, V Samakhovets, P Surmont, H A Ramírez Reyes, M Winter, F Prunier, B Cavert, B Salaun, J M Roca Catalán, A Beinhauer, Ian Ford, K Elsby, V Knyazeva, C Tamburino, V Khoury, A Felice Castro Issa, B Marchenko, K König, A Kennedy, J M Alegret Colomer, T Gillet, Clarify Investigators, B Maheu, A Troncoso Gil, N Haldane, B Koujan, T Mouhat, A Waldman, J Robert, J Campbell, A Kokis, M Micheals, P Gori, P Ramoutar, M Al Zaibag, V Ryzhkova, M Kazakovtseva, C Bernardeau, B Ferreiro Rodríguez, Y Voloshko, S Szabo, I Jarvis, Y N Ke, J Donetti, A Serrano-Garcia, R Ketelers, S Grigoryan, V Kulik, P Zündorf, L Kleemann, J McPherson, M Luaces Méndez, F Mouquet, L G Xiong, T H Tran, P Costello, A Potter, M Cinteza, F Colivicchi, E Nowicka, O Greiner, G Reddy, M Martins Oliveira, F Fernandes De Sousa, P Nocon, R Sewell, I Nikodemska, R Tadeu Munhoz, T Gilbert, I Laizane, M Maroun, B Demianiuk, A Bolidai, R Kacorzyk, R Fernández Mouzo, K Karastanev, J Blanco Castiñeiras, P Messali, R Schwarz, M Vardhani, O Gouli, C Thelemann, A Forclaz, G Khaznadar, G Eisele, P Sosner, M L Bourachot, N Pontikakis, S Heinemann-Meerz, E Zatsarina, E Smrckova, P Calmettes, D H Kang, M L Santos Iglesias, S M Marinescu, A Heap, Melnikova, N F Strathmore, S Tolpygina, M Yang, M Naisseh, E George, J Banach, E Delcoulx, E Teijeira Fernández, J Poles, P Saunders, S Haddad, T Q Luu, A Dhesi, O Prikolota, M Baar, P Lafontaine, C O'Dong, I Petropoulos, B-M Altevogt, D Warden, T De Backer, G Miñana Escrivá, T L Mai, U Schlesinger-Irsch, M M Gomaa, E Moksyuta, M Drexler, P Monteiro, P Grooterhorst, J Moolman, P McAlavey, J O'Shea, L P Quinn, F Crespo, K Srinivasa Reddy, T Shokina, Ellen M. Schmidt, M H Jeong, K Denef, A Pleskof, I Takács, Y Tikhonov, O Ushakov, L Stevens, J Ezcurdia Sasieta, L Nkombua, O Henne Otero, J Y Fraboulet, D S Kim, G Hoh, A Tamm, M Sardon, G Chatzioakim, M A Ulecia Martínez, S Reymond, M Myint, G Proença, R Massabie, E Foster, H Dougall, Anjan Kumar Roy, C Franco Aranda, M Getman, E Filippova, C Aguiar, X D Pu, N Voronina, L L Chen, M Szulc, L Bayakhchan, M J Pinto Vaz, C Niederberger, N Vites, I Sen, Paul R. Kalra, J A Castillo Moreno, W K Ng, C Brunschwig, D Morgan, A Concepción Clemente, N Yakimova, J M Guy, A H Jaafar, J Badarienė, N Taylor, L Compson, R Amor, A Maximovitch, J L Bardají Mayor, E Marín Araez, N H Chau, N Srtumilenko, K Kelly, A Papathanasioy, S Erofeev, B Mamez, A Ribeiro, M Micko, N Alvarenga Recalde, K Atueva, Z Sebõk, P Kycina, A K Gupta, A Laucevičius, R Ahuja, A Prokop, P Stadler, S De Ridder, L Zhang, F B Ramadan, L Kapustina, V Fedoskin, A Bateman, C A Nacht, R Musetescu, M Aparici Feal, A Büttl, S Ross, M Rau, P Federico Zaragoza, G Brisson, M Zagreanu, T T H Pham, F Dominé, N Davydova, N Petrochenko, N Paul, P H Truong, S Frickel, W Bryl, G Brouillette, A Stumpp, M Barrera Bustillos, C Ziccarelli, O Zalyzniak, M eatherhead, N Watkins, G Riccioni, l Kudryavtsev, R Carvalho, J P S Sawhney, V González Toda, P Matos Dias, M Giorgadze, I Rodriguez Marrero, W Gritsch, K Lee, G W Kellam, I Parker, V Ecina, Mª I Soto Ruiz, C Delhomme, T Ivaschenko, Y W Cheah, I Grudtsina, R Chehayeb, T Dookie, O Krasnoslobodskaya, P Jarmużek, F Van den Branden, A M F Vandeplas, A Rocha De Almeida, M Espiga De Macedo, E Łotocka, K Nagy, R Paliulionienė, J L Leyva Pons, N Fedorova, Y Yanina, O Stasuk, Z Vlasuk, P Lim, P Egloff, T Berezhna, A Faria, J Cerda Rojas, E Moser, H G Jin, S J Oh, G Arquero García, K H Karner, I Leontaridis, A Banikova, J Fridrich, H Lesseliers, I Pokrovskaya, P Astridge, H Abdul Manap, R Daniel, C A Almeida Fernández, A Nowowiejska-Wiewióra, B Carvalho De Moura, M Malden, H Rosenstein, S Dixon, G Balogh, M Adam-Blanpain, A Sandalian, H Gervas Pavón, G A Antoniadis, N Naberezhnova, A Amlaiky, P Terrosu, K K H Lau, B Chartier, X Su, O Kovyrshyna, G Beale, P Primot, M H Chen, S S Ramesh, R Chyrek, E Gómez Álvarez, J Rodríguez Collado, G Sibilio, R Jeremiasz, R Colin, C Lalla, G M Fullerton, M P Samal, H Thümmel, R P Patel, J Takhar, H M Kwon, T A Cieza Lara, F Magliari, J Morrell, M Rayo Gutiérrez, T L Orenstein-Lyall, H Choi, S Kulinich, A Aftab, A Wallace, B B Abdul Kareem, S Kwok, A Królak, A Grover, Laurent Fauchier, Mª J Pinilla Lozano, G Sengupta, D Paris, M Al Dhanki, J Milewski, F Petersen Aranguren, H Brufau Redondo, H Mayr, A Arias Mendoza, M Ducoudre, A Correia, J S Awtar Singh, P Aylward, E Brscic, J Du Plooy, J L Arenas León, G Silva Alves, L Sreenivasa Murthy, P Dendale, F La Varra, S Minkin, T Eggeling, A Jamiel, G Lebischak, E Andreev, T V A Tuong, V Chaithiraphan, O Duprez, S Higgins, F Chometon, Y Cottin, A Bonny, C Guyetand, J Matos, F Henpin Yue Cesena, L Polyaeva, M Drijfhout, J Toplak, G E Vertes, N F Wang, J Doucet, A K Trivedi, P Turek, G Chouinard, A Al Lawati, W Filip, F Kovar, T J Cha, A Belanger, H L Cong, J F Robert, D López Gómez, J L Sanz Rodríguez, H Simper, P Shetty, A Chukwu, E Bukanina, C Amoros Galito, H MacCowan, T T T Tran, A Singal, K C Vu, O Ismail, A Ardiaca Capell, P Bousquet, F Goss, Z Galeeva, Maxime Guenoun, B Rijavec, Z Lazerevic, A McCracken, A C Motoc, Y Sharapova, S Wright, A J Paule Sánchez, L Mainar Latorre, I Sirazov, X L Yang, S E Paget, G Berkenboom, J Markenvard, I Surovtseva, S K George, Matthias Simon, M L Fuantos Delgado, C Christoforidis, M Lagares Carballo, P Alvarez García, J Könemann, L Crawford, I Gonos, D Saulnier, E Szabó, L Ardouin, J Bhayat, F J Abardía Oliva, X Bernard, O Sirbu, P Boutsikos, N Khmelevskikh, E Tavlueva, P LeBouthillier, I Bourazanis, A Sequeira, M López Martínez, C P Paulus, R K M Bhaskaran, F Pellerin, B Brown, B Saleh, A Lacchè, R Sola Casado, E Kaźmierczak, M Weingrod, and G Vijayaraghavan
- Subjects
medicine.medical_specialty ,Cardiac & Cardiovascular Systems ,Epidemiology ,LONG-TERM ,medicine.medical_treatment ,Chronic coronary syndromes ,Coronary Artery Disease ,Revascularization ,Ventricular Function, Left ,GLUCOSE ,MELLITUS ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,Ethnicity ,Prevalence ,medicine ,Humans ,ARTERY-DISEASE ,Myocardial infarction ,Stroke ,RISK ,OUTCOMES ,Ejection fraction ,Science & Technology ,business.industry ,Proportional hazards model ,CLARIFY Investigators ,Hazard ratio ,Diabetes ,Stroke Volume ,Geographical disparities ,Syndrome ,medicine.disease ,MIDDLE-EAST ,EUROPEAN-SOCIETY ,Treatment Outcome ,MYOCARDIAL-INFARCTION ,Heart failure ,CLARIFY registry ,Cardiovascular System & Cardiology ,HEART-FAILURE ,Cardiology and Cardiovascular Medicine ,business ,Life Sciences & Biomedicine - Abstract
BackgroundIn contrast with the setting of acute myocardial infarction, there are limited data regarding the impact of diabetes mellitus on clinical outcomes in contemporary cohorts of patients with chronic coronary syndromes. We aimed to investigate the prevalence and prognostic impact of diabetes according to geographical regions and ethnicity.Methods and resultsCLARIFY is an observational registry of patients with chronic coronary syndromes, enrolled across 45 countries in Europe, Asia, America, Middle East, Australia, and Africa in 2009–2010, and followed up yearly for 5 years. Chronic coronary syndromes were defined by ≥1 of the following criteria: prior myocardial infarction, evidence of coronary stenosis >50%, proven symptomatic myocardial ischaemia, or prior revascularization procedure.Among 32 694 patients, 9502 (29%) had diabetes, with a regional prevalence ranging from below 20% in Northern Europe to ∼60% in the Gulf countries. In a multivariable-adjusted Cox proportional hazards model, diabetes was associated with increased risks for the primary outcome (cardiovascular death, myocardial infarction, or stroke) with an adjusted hazard ratio of 1.28 (95% confidence interval 1.18, 1.39) and for all secondary outcomes (all-cause and cardiovascular mortality, myocardial infarction, stroke, heart failure, and coronary revascularization). Differences on outcomes according to geography and ethnicity were modest.ConclusionIn patients with chronic coronary syndromes, diabetes is independently associated with mortality and cardiovascular events, including heart failure, which is not accounted by demographics, prior medical history, left ventricular ejection fraction, or use of secondary prevention medication. This is observed across multiple geographic regions and ethnicities, despite marked disparities in the prevalence of diabetes.ClinicalTrials identifierISRCTN43070564
- Published
- 2021
3. EXPERIMENTAL VERIFICATION OF STRUCTURAL-ACOUSTIC MODELLING AND DESIGN OPTIMIZATION
- Author
-
Steffen Marburg, J. Gier, F. Perret, H.-J. Hardtke, H.-J. Beer, and R. Rennert
- Subjects
Engineering ,Acoustics and Ultrasonics ,business.industry ,Mechanical Engineering ,Numerical analysis ,Modal analysis ,Structural engineering ,Condensed Matter Physics ,Transfer function ,Finite element method ,Stiffening ,Noise ,Mechanics of Materials ,business ,Structural acoustics ,Beam (structure) - Abstract
A number of papers have been published on the simulation of structural-acoustic design optimization. However, extensive work is required to verify these results in practical applications. Herein, a steel box of 1.0×1.1×1.5 meters with an external beam structure welded on three surface plates was investigated. This investigation included experimental modal analysis and experimental measurements of certain noise transfer functions (sound pressure at points inside the box due to force excitation at beam structure). Using these experimental data, the finite element model of the structure was tuned to provide similar results. With a first structural mode at less than 20 Hertz the reliable frequency range was identified up to about 60 Hertz. Obviously, the finite element model could not be further improved only by mesh refinement. The tuning process will be explained in detail since there was a number of changes that helped to improve the structure. Other changes did not improve the structure. Although this model of the box could be expected as a rather simple structure it can be considered to be a complex structure for simulation purposes. A defined modification of the physical model verified the simulation model. In a final step, the optimal location of stiffening beam structures was predicted by simulation. Their effect on the noise transfer function was experimentally verified. This paper critically discusses modeling techniques that are applied for structural-acoustic simulation of sedan bodies.
- Published
- 2002
4. Abstract 171
- Author
-
Michael Findlay, Zeshaan N. Maan, Jason P. Glotzbach, Kevin J. Paik, Atul J. Butte, Dominik Duscher, Revanth Kosaraju, Michael Sorkin, R Rennert, Michael Januszyk, Melanie Rodrigues, Geoffrey C. Gurtner, and Michael T. Chung
- Subjects
Surface (mathematics) ,medicine.anatomical_structure ,business.industry ,Cell ,Medicine ,Surgery ,Identification (biology) ,Computational biology ,business - Published
- 2015
5. Abstract 172
- Author
-
Geoffrey C. Gurtner, Michael Januszyk, Purvesh Khatri, Nadine Jahchan, Julien Sage, Atul J. Butte, Michael T. Longaker, R Rennert, and Michael Sorkin
- Subjects
Gene expression profiling ,medicine.anatomical_structure ,business.industry ,Microarray analysis techniques ,Cell ,Medicine ,Cancer ,Surgery ,Computational biology ,business ,medicine.disease - Published
- 2015
6. Abstract 12
- Author
-
Robert R. Rennert, Shane D. Morrison, Peter A. Than, Michael Findlay, Geoffrey C. Gurtner, Tai Le, and Christopher R. Davis
- Subjects
Minicircle dna ,business.industry ,Genetic enhancement ,Medicine ,Surgery ,Transfection ,Free flap ,business ,Molecular biology ,Ex vivo - Published
- 2015
7. LoGen -- Generation and Simulation of Digital Logic on the Gate-Level via Internet
- Author
-
S. Kubisch, Dirk Timmermann, H. Pfueller, and R. Rennert
- Subjects
Academic education ,Multimedia ,business.industry ,Computer science ,Logic gate ,Electronic engineering education ,The Internet ,computer.software_genre ,business ,Computer aided instruction ,Everyday life ,computer - Abstract
The Internet is omnipresent. Everyone uses the Internet for information retrieval and communication. It is part and parcel of everyday life and culture. This is also true for all levels of preschool and academic education as well as on-the-job training. Currently, providing learning objects on an electronic and personalized base is widely favored and -- in the meantime -- common practice. We present LoGen, a browser-based tool for the generation and simulation of digital, logic circuits on the gate-level via Internet. This tool is used as additional learning module for lectures and exercises at the Institute of Applied Microelectronics and Computer Engineering, University of Rostock. The feasibility of standard HTML for suchlike applications is pointed out. For the design of the tool, solely approved and well-established Internet-technologies have been used. It is especially feasible for so-called thin clients. It is shown that the Internet with its broad repertoire of basic functions and services is well suited for this kind of applications.
- Published
- 2006
8. An Experimental Verification of Structural-Acoustic Modeling and Design Optimization
- Author
-
H.-J. Beer, J. Gier, H.-J. Hardtke, S. Marburg, F. Perret, and R. Rennert
- Published
- 2002
9. LOP23
- Author
-
Geoffrey C. Gurtner, David Atashroo, Kshemendra Senarath-Yapa, Zeshaan N. Maan, M Hu, R Rennert, Ruth Tevlin, Elizabeth R. Zielins, D. Duscher, Melanie Rodrigues, Adrian McArdle, M.T. Longaker, G G Walmsley, Michael Januszyk, and Alexander J. Whittam
- Subjects
business.industry ,Adipose tissue ,Medicine ,Cell subpopulations ,Surgery ,business ,Cell biology - Published
- 2014
10. Abstract 182
- Author
-
R Rennert, Geoffrey C. Gurtner, Michael Sorkin, Michael T. Chung, Michael Januszyk, and M.T. Longaker
- Subjects
medicine.anatomical_structure ,business.industry ,Cell ,medicine ,Adipose tissue ,Surgery ,Identification (biology) ,Transcriptional analysis ,business ,Cell biology - Published
- 2013
11. Abstract 181
- Author
-
Chunjun Liu, G G Walmsley, David Lo, Kshemendra Senarath-Yapa, HH Chen, Michael T. Chung, Derrick C. Wan, Michael Sorkin, JS Hyun, R Rennert, Kevin J. Paik, M Hu, AS Chung, A.S. Zimmermann, Daniel T. Montoro, Adrian McArdle, and M.T. Longaker
- Subjects
business.industry ,Bone morphogenetic protein 8b ,Bone morphogenetic protein 8A ,Bone morphogenetic protein 10 ,Anatomy ,Bone morphogenetic protein 2 ,Cell biology ,Bone morphogenetic protein 7 ,Bone morphogenetic protein 6 ,Bone morphogenetic protein 5 ,Medicine ,Surgery ,Bone morphogenetic protein receptor ,business - Published
- 2013
12. Abstract 175
- Author
-
HH Chen, M.T. Longaker, Adrian McArdle, Daniel T. Montoro, Derrick C. Wan, Michael T. Chung, David Lo, A.S. Zimmermann, Michael Sorkin, R Rennert, Kevin T Paik, AS Chung, Chunjun Liu, Kshemendra Senarath-Yapa, G G Walmsley, and JS Hyun
- Subjects
medicine.medical_specialty ,Stromal cell ,business.industry ,Adipose tissue ,Cell assisted lipotransfer ,Cell biology ,Bone morphogenetic protein 7 ,Bone morphogenetic protein 6 ,Endocrinology ,Internal medicine ,Medicine ,Surgery ,Bone morphogenetic protein receptor ,business - Published
- 2013
13. Abstract 179
- Author
-
M Hu, Daniel T. Montoro, HH Chen, JS Hyun, Shane D. Morrison, R Rennert, Kevin J. Paik, Adrian McArdle, David Lo, G G Walmsley, Derrick C. Wan, A.S. Zimmermann, AS Chung, M.T. Longaker, Chunjun Liu, Kshemendra Senarath-Yapa, Michael Sorkin, and Michael T. Chung
- Subjects
Stromal cell ,business.industry ,Modulation ,Surface marker ,Adipose tissue ,Medicine ,Surgery ,business ,Cell biology - Published
- 2013
14. Abstract 91
- Author
-
Jason P. Glotzbach, Jerry S. Chen, Michael Januszyk, Michael Sorkin, Geoffrey C. Gurtner, Victor W. Wong, R Rennert, Kristine C. Rustad, and M.T. Longaker
- Subjects
medicine.anatomical_structure ,business.industry ,Cell ,medicine ,Adipose tissue ,Surgery ,Transcriptional analysis ,business ,Gene ,Cell biology - Published
- 2012
15. Abstract 3
- Author
-
M.T. Longaker, Satoshi Akaishi, Ravi K. Garg, R Rennert, Wei Liu, Victor W. Wong, Geoffrey C. Gurtner, Kristine C. Rustad, and Michael Sorkin
- Subjects
Focal adhesion ,Chronic wound ,Pathology ,medicine.medical_specialty ,Murine model ,business.industry ,Ultimate tensile strength ,medicine ,Surgery ,medicine.symptom ,business - Published
- 2012
16. Abstract 14
- Author
-
Shane D. Morrison, R Rennert, Ravi K. Garg, Michael Sorkin, M.T. Longaker, and Geoffrey C. Gurtner
- Subjects
Minicircle dna ,business.industry ,Transgene ,Medicine ,Surgery ,business ,Cell biology - Published
- 2012
17. Detailed Analysis Concerning the Biodistribution and Metabolism of Human Calcitonin-Derived Cell-Penetrating Peptides.
- Author
-
I. Neundorf, R. Rennert, J. Franke, I. Közle, and R. Bergmann
- Published
- 2008
- Full Text
- View/download PDF
18. Variation in the dissociation lifetimes of triplet acetophenone and p-trifluoromethylacetophenone as a function of excitation energy
- Author
-
Colin Steel and Abraham R. Rennert
- Subjects
chemistry.chemical_compound ,Chemistry ,Excited state ,Critical energy ,Photodissociation ,General Physics and Astronomy ,Physical and Theoretical Chemistry ,Atomic physics ,Photochemistry ,Dissociation (chemistry) ,Excitation ,Acetophenone - Abstract
At low pressures either S0-S2 or S0-S3 excitation of acetophenone (I) and p-trifluoromethylacetophenone (II) leads to a cleavage with nearly unit efficiency. This photodissociation accounts for the short lifetimes of vibrationally excited lead II. RRKM calculations indicate that the critical energy in both cases is ≈20 kcal mol , somewhat greater than the endothermicity.
- Published
- 1981
19. Breast-milk composition in women with cystic fibrosis: report of two cases and a review of the literature
- Author
-
M L, Shiffman, T W, Seale, M, Flux, O R, Rennert, and P T, Swender
- Subjects
Adult ,Pregnancy Complications ,Breast Feeding ,Chlorides ,Cystic Fibrosis ,Milk, Human ,Pregnancy ,Sodium ,Potassium ,Humans ,Female ,Lactose ,Milk Proteins - Abstract
Breast milk was collected from two women with cystic fibrosis (CF) and data from the literature was reviewed. The sodium concentration was within normal limits, 11-24 mmol/L in colostrum and 7-8 mmol/L in mature milk. Normal physiologic changes in milk composition after parturition (decreases in Na and increases in lactose) and during individual feeding periods (increases in fat and decreases in protein) were observed. Concentrations of milk protein, fat, and sugars were normal when the pulmonary disease of these patients was mild. During exacerbations of pulmonary disease, the concentrations of milk macronutrients were reduced. Milk secreted by women with CF appears to be physiologically normal, safe for the infant, and breast-feeding by mothers with CF should no longer be discouraged. Variations in the macronutrient content of CF milk warrants routine monitoring of the mother with CF and the breast-fed infant, especially during exacerbations in the pulmonary aspects of this disease.
- Published
- 1989
20. Novel Zn(II), Co(II) and Cu(II) diflunisalato complexes with neocuproine and their exceptional antiproliferative activity against cancer cell lines.
- Author
-
Smolková R, Smolko L, Samoľová E, Morgan I, Rennert R, and Kaluđerović GN
- Subjects
- Humans, Cell Line, Tumor, Apoptosis drug effects, Drug Screening Assays, Antitumor, Phenanthrolines chemistry, Phenanthrolines pharmacology, Models, Molecular, Copper chemistry, Copper pharmacology, Zinc chemistry, Zinc pharmacology, Cell Proliferation drug effects, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry, Antineoplastic Agents chemical synthesis, Coordination Complexes pharmacology, Coordination Complexes chemistry, Coordination Complexes chemical synthesis, Cobalt chemistry, Cobalt pharmacology
- Abstract
Three novel complexes of deprotonated diflunisal ( dif ) with neocuproine ( neo ) were synthesized and characterized via elemental, spectral (UV-vis, FTIR, fluorescence, and mass spectrometry), and single-crystal X-ray diffraction analyses. Although the compounds shared a similar composition of [MCl( dif )( neo )], where M represents Zn(II) (1), Co(II) (2) and Cu(II) (3), only 1 and 2 were isostructural, while 3 differed in both the molecular and supramolecular structures. In all three complex molecules, the central atom is coordinated by two nitrogen atoms of neo in a bidentate chelate mode, and one chlorido ligand and dif is bonded in either a monodentate mode via one oxygen atom of the carboxylate in 1 and 2 or in a bidentate chelate mode via both carboxylate oxygen atoms in 3. All three compounds demonstrated remarkable antiproliferative activity against human prostate (PC-3), colon (HCT116) and breast (MDA-MB-468) cancer cell lines with IC
50 values in the nanomolar range, with the lowest values observed in the case of PC-3 and MDA-MB-468 with 2 (20.0 nM) and 3 (31.1 nM), respectively. Moreover, complex 2, as the most active, was further investigated for its potential to induce perturbations in the cell cycle of PC-3 cells. The results indicated an induction of caspase-independent apoptosis. The interaction of the complexes with genomic DNA isolated from the respective cancer cell lines was evaluated for the intercalative mode, with binding strength correlated with the antiproliferative activity against PC-3 and MDA-MB-468 cancer cell lines.- Published
- 2024
- Full Text
- View/download PDF
21. Advancing Anticancer Drug Discovery: Leveraging Metabolomics and Machine Learning for Mode of Action Prediction by Pattern Recognition.
- Author
-
Saoud M, Grau J, Rennert R, Mueller T, Yousefi M, Davari MD, Hause B, Csuk R, Rashan L, Grosse I, Tissier A, Wessjohann LA, and Balcke GU
- Abstract
A bottleneck in the development of new anti-cancer drugs is the recognition of their mode of action (MoA). Metabolomics combined with machine learning allowed to predict MoAs of novel anti-proliferative drug candidates, focusing on human prostate cancer cells (PC-3). As proof of concept, 38 drugs are studied with known effects on 16 key processes of cancer metabolism, profiling low molecular weight intermediates of the central carbon and cellular energy metabolism (CCEM) by LC-MS/MS. These metabolic patterns unveiled distinct MoAs, enabling accurate MoA predictions for novel agents by machine learning. The transferability of MoA predictions based on PC-3 cell treatments is validated with two other cancer cell models, i.e., breast cancer and Ewing's sarcoma, and show that correct MoA predictions for alternative cancer cells are possible, but still at some expense of prediction quality. Furthermore, metabolic profiles of treated cells yield insights into intracellular processes, exemplified for drugs inducing different types of mitochondrial dysfunction. Specifically, it is predicted that pentacyclic triterpenes inhibit oxidative phosphorylation and affect phospholipid biosynthesis, as confirmed by respiration parameters, lipidomics, and molecular docking. Using biochemical insights from individual drug treatments, this approach offers new opportunities, including the optimization of combinatorial drug applications., (© 2024 The Author(s). Advanced Science published by Wiley‐VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
22. Improved Access to Potent Anticancer Tubulysins and Linker-Functionalized Payloads Via an All-On-Resin Strategy.
- Author
-
Ricardo MG, Llanes D, Rennert R, Jänicke P, Rivera DG, and Wessjohann LA
- Subjects
- Humans, Immunoconjugates chemistry, Quaternary Ammonium Compounds chemistry, Oligopeptides chemistry, Cell Line, Tumor, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology
- Abstract
Tubulysins are among the most recent antimitotic compounds to enter into antibody/peptide-drug conjugate (ADC/PDC) development. Thus far, the design of the most promising tubulysin payloads relied on simplifying their structures, e. g., by using small tertiary amide N-substituents (Me, Et, Pr) on the tubuvaline residue. Cumbersome solution-phase approaches are typically used for both syntheses and functionalization with cleavable linkers. p-Aminobenzyl quaternary ammonium (PABQ) linkers were a remarkable advancement for targeted delivery, but the procedures to incorporate them into tubulysins are only of moderate efficiency. Here we describe a novel all-on-resin strategy permitting a loss-free resin linkage and an improved access to super potent tubulysin analogs showing close resemblance to the natural compounds. For the first time, a protocol enables the integration of on-resin tubulysin derivatization with, e. g., a maleimido-Val-Cit-PABQ linker, which is a notable progress for the payload-PABQ-linker technology. The strategy also allows tubulysin diversification of the internal amide N-substituent, thus enabling to screen a tubulysin library for the discovery of new potent analogs. This work provides ADC/PDC developers with new tools for both rapid access to new derivatives and easier linker-attachment and functionalization., (© 2024 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
23. Comparison of Balanites aegyptiaca parts: metabolome providing insights into plant health benefits and valorization purposes as analyzed using multiplex GC-MS, LC-MS, NMR-based metabolomics, and molecular networking.
- Author
-
Farag MA, Baky MH, Morgan I, Khalifa MR, Rennert R, Mohamed OG, El-Sayed MM, Porzel A, Wessjohann LA, and Ramadan NS
- Abstract
Balanites aegyptiaca (L.) Delile (Zygophyllaceae), also known as the desert date, is an edible fruit-producing tree popular for its nutritional and several health benefits. In this study, multi-targeted comparative metabolic profiling and fingerprinting approaches were conducted for the assessment of the nutrient primary and secondary metabolite heterogeneity in different parts, such as leaves, stems, seeds, unripe, and ripe fruits of B. aegyptiaca using nuclear magnetic resonance (NMR), ultra-performance liquid chromatography (UPLC-MS), and gas chromatography mass-spectrometry (GC-MS) based metabolomics coupled to multivariate analyses and in relation to its cytotoxic activities. NMR-based metabolomic study identified and quantified 15 major primary and secondary metabolites belonging to alkaloids, saponins, flavonoids, sugars, and amino and fatty acids. Principal component analysis (PCA) of the NMR dataset revealed α-glucose, sucrose, and isorhamnetin as markers for fruit and stem and unsaturated fatty acids for predominated seeds. Orthogonal projections to latent structure discriminant analysis (OPLS-DA) revealed trigonelline as a major distinctive metabolite in the immature fruit and isorhamnetin as a major distinct marker in the mature fruit. UPLC-MS/MS analysis using feature-based molecular networks revealed diverse chemical classes viz. steroidal saponins, N-containing metabolites, phenolics, fatty acids, and lipids as the constitutive metabolome in Balanites . Gas chromatography-mass spectroscopy (GC-MS) profiling of primary metabolites led to the detection of 135 peaks belonging to sugars, fatty acids/esters, amino acids, nitrogenous, and organic acids. Monosaccharides were detected at much higher levels in ripe fruit and disaccharides in predominate unripe fruits, whereas B. aegyptiaca vegetative parts (leaves and stem) were rich in amino acids and fatty acids. The antidiabetic compounds, viz , nicotinic acid, and trigonelline, were detected in all parts especially unripe fruit in addition to the sugar alcohol d-pinitol for the first time providing novel evidence for B. aegyptiaca use in diabetes. In vitro cytotoxic activity revealed the potential efficacy of immature fruit and seeds as cytotoxic agents against human prostate cancer (PC3) and human colorectal cancer (HCT-116) cell lines. Collectively, such detailed profiling of parts provides novel evidence for B. aegyptiaca medicinal uses., Competing Interests: There is no conflict of interest., (This journal is © The Royal Society of Chemistry.)
- Published
- 2023
- Full Text
- View/download PDF
24. Awakening the sleeping giant of urban green in times of crisis-coverage, co-creation and practical guidelines for optimizing biodiversity-friendly and health-promoting residential greenery.
- Author
-
Mohr-Stockinger S, Sanft SJ, Büttner F, Butenschön S, Rennert R, and Säumel I
- Subjects
- Cities, Health Status, Berlin, Public Health, Biodiversity
- Abstract
As multiple crises deepen existing inequalities in urban societies within and between neighborhoods, strategically integrating nature-based solutions into the living environment can help reduce negative impacts and improve public health, social cohesion, and well-being. Compared to public green such as parks, semi-public residential greenery is rarely studied, is regularly overlooked by planners, and often receives step-motherly treatment from architects and housing companies. We approximated the area of residential greenery of modernist multi-story apartment complexes in Berlin, Germany. We surveyed residents' suggestions for improving their living environments in vulnerable neighborhoods, report on co-creation experiences, and provide a practical guideline for optimizing health-promoting residential green spaces. The semi-public open space on the doorstep of two-thirds of Berlin's population is highly fragmented and, in total, has a similar area as the public green spaces and a great potential for qualitative development. Just as the suitability of different nature-based solutions to be integrated into the residential greenery depends on building types, resident demands differ between neighborhoods. Residents called for more involvement in design, implementation, and maintenance, frequently proposing that biodiversity-friendly measures be included. As there is no universal solution even for neighborhoods sharing similar structural and socioeconomic parameters, we propose, and have tested, an optimization loop for health-promoting residential greening that involves exploring residents' needs and co-creating local solutions for urban regeneration processes that can be initiated by different actors using bottom-up and/or top-down approaches in order to unlock this potential for healthy, livable and biodiversity friendly cities., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Mohr-Stockinger, Sanft, Büttner, Butenschön, Rennert and Säumel.)
- Published
- 2023
- Full Text
- View/download PDF
25. Purpurascenines A-C, Azepino-Indole Alkaloids from Cortinarius purpurascens : Isolation, Biosynthesis, and Activity Studies on the 5-HT 2A Receptor.
- Author
-
Lam YTH, Hoppe J, Dang QN, Porzel A, Soboleva A, Brandt W, Rennert R, Hussain H, Davari MD, Wessjohann L, and Arnold N
- Subjects
- Male, Humans, Receptor, Serotonin, 5-HT2A, Indole Alkaloids pharmacology, Serotonin metabolism, Serotonin pharmacology, Cortinarius chemistry, Cortinarius metabolism
- Abstract
Three previously undescribed azepino-indole alkaloids, named purpurascenines A-C ( 1 - 3 ), together with the new-to-nature 7-hydroxytryptophan ( 4 ) as well as two known compounds, adenosine ( 5 ) and riboflavin ( 6 ), were isolated from fruiting bodies of Cortinarius purpurascens Fr. (Cortinariaceae). The structures of 1 - 3 were elucidated based on spectroscopic analyses and ECD calculations. Furthermore, the biosynthesis of purpurascenine A ( 1 ) was investigated by in vivo experiments using
13 C-labeled sodium pyruvate, alanine, and sodium acetate incubated with fruiting bodies of C. purpurascens . The incorporation of13 C into 1 was analyzed using 1D NMR and HRESIMS methods. With [3-13 C]-pyruvate, a dramatic enrichment of13 C was observed, and hence a biosynthetic route via a direct Pictet-Spengler reaction between α-keto acids and 7-hydroxytryptophan ( 4 ) is suggested for the biosynthesis of purpurascenines A-C ( 1 - 3 ). Compound 1 exhibits no antiproliferative or cytotoxic effects against human prostate (PC-3), colorectal (HCT-116), and breast (MCF-7) cancer cells. An in silico docking study confirmed the hypothesis that purpurascenine A ( 1 ) could bind to the 5-HT2A serotonin receptor's active site. A new functional 5-HT2A receptor activation assay showed no functional agonistic but some antagonistic effects of 1 against the 5-HT-dependent 5-HT2A activation and likely antagonistic effects on putative constitutive activity of the 5-HT2A receptor.- Published
- 2023
- Full Text
- View/download PDF
26. Calibration procedure and biomechanical validation of an universal six degree-of-freedom robotic system for hip joint testing.
- Author
-
Rychlik M, Wendland G, Jackowski M, Rennert R, Schaser KD, and Nowotny J
- Subjects
- Humans, Calibration, Hip Joint, Acetabulum, Femur, Robotic Surgical Procedures
- Abstract
Purpose: Among various test methods for different human joints, the use of robot systems has attracted major interest and inherits the potential to become a gold standard in biomechanical testing in the future. A key issue associated with those robot-based platforms is the accurate definition of parameters, e.g., tool center point (TCP), length of tool or anatomical trajectories of movements. These must be precisely correlated to the physiological parameters of the examined joint and its corresponding bones. Exemplified for the human hip joint, we are creating an accurate calibration procedure for a universal testing platform by using a six degree-of-freedom (6 DOF) robot and optical tracking system for recognition of anatomical movements of the bone samples., Methods: A six degree-of-freedom robot (TX 200, Stäubli) has been installed and configured. The physiological range of motion of the hip joint composed of a femur and a hemipelvis was recorded with an optical 3D movement and deformation analysis system (ARAMIS, GOM GmbH). The recorded measurements were processed by automatic transformation procedure (created in Delphi software) and evaluated in 3D CAD system., Results: The physiological ranges of motion were reproduced for all degrees of freedom with the six degree-of-freedom robot in adequate accuracy. With the establishment of a special calibration procedure by using a combination of different coordinate systems, we were able to achieve a standard deviation of the TCP depending of the axis between 0.3 and 0.9 mm and for the length of tool between + 0.67 and - 0.40 mm (3D CAD processing) resp. + 0.72 mm to - 0.13 mm (Delphi transformation). The accuracy between the manual and robotic movement of the hip shows an average deviation between - 0.36 and + 3.44 mm for the points on the movement trajectories., Conclusion: A six degree-of-freedom robot is appropriate to reproduce the physiological range of motion of the hip joint. The described calibration procedure is universal and can be used for hip joint biomechanical tests allowing to apply clinically relevant forces and investigate testing stability of reconstructive osteosynthesis implant/endoprosthetic fixations, regardless of the length of the femur, size of the femoral head and acetabulum or whether the entire pelvis or only the hemipelvis will be used., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
27. Does filter-aided sample preparation provide sufficient method linearity for quantitative plant shotgun proteomics?
- Author
-
Leonova T, Ihling C, Saoud M, Frolova N, Rennert R, Wessjohann LA, and Frolov A
- Abstract
Due to its outstanding throughput and analytical resolution, gel-free LC-based shotgun proteomics represents the gold standard of proteome analysis. Thereby, the efficiency of sample preparation dramatically affects the correctness and reliability of protein quantification. Thus, the steps of protein isolation, solubilization, and proteolysis represent the principal bottleneck of shotgun proteomics. The desired performance of the sample preparation protocols can be achieved by the application of detergents. However, these compounds ultimately compromise reverse-phase chromatographic separation and disrupt electrospray ionization. Filter-aided sample preparation (FASP) represents an elegant approach to overcome these limitations. Although this method is comprehensively validated for cell proteomics, its applicability to plants and compatibility with plant-specific protein isolation protocols remain to be confirmed. Thereby, the most important gap is the absence of the data on the linearity of underlying protein quantification methods for plant matrices. To fill this gap, we address here the potential of FASP in combination with two protein isolation protocols for quantitative analysis of pea ( Pisum sativum ) seed and Arabidopsis thaliana leaf proteomes by the shotgun approach. For this aim, in comprehensive spiking experiments with bovine serum albumin (BSA), we evaluated the linear dynamic range (LDR) of protein quantification in the presence of plant matrices. Furthermore, we addressed the interference of two different plant matrices in quantitative experiments, accomplished with two alternative sample preparation workflows in comparison to conventional FASP-based digestion of cell lysates, considered here as a reference. The spiking experiments revealed high sensitivities (LODs of up to 4 fmol) for spiked BSA and LDRs of at least 0.6 × 10
2 . Thereby, phenol extraction yielded slightly better recoveries, whereas the detergent-based method showed better linearity. Thus, our results indicate the very good applicability of FASP to quantitative plant proteomics with only limited impact of the protein isolation technique on the method's overall performance., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Leonova, Ihling, Saoud, Frolova, Rennert, Wessjohann and Frolov.)- Published
- 2022
- Full Text
- View/download PDF
28. Language and developmental plasticity after perinatal stroke.
- Author
-
Newport EL, Seydell-Greenwald A, Landau B, Turkeltaub PE, Chambers CE, Martin KC, Rennert R, Giannetti M, Dromerick AW, Ichord RN, Carpenter JL, Berl MM, and Gaillard WD
- Subjects
- Adolescent, Brain physiology, Brain Mapping methods, Child, Child, Preschool, Functional Laterality physiology, Humans, Magnetic Resonance Imaging methods, Neuronal Plasticity physiology, Young Adult, Language, Stroke
- Abstract
The mature human brain is lateralized for language, with the left hemisphere (LH) primarily responsible for sentence processing and the right hemisphere (RH) primarily responsible for processing suprasegmental aspects of language such as vocal emotion. However, it has long been hypothesized that in early life there is plasticity for language, allowing young children to acquire language in other cortical regions when LH areas are damaged. If true, what are the constraints on functional reorganization? Which areas of the brain can acquire language, and what happens to the functions these regions ordinarily perform? We address these questions by examining long-term outcomes in adolescents and young adults who, as infants, had a perinatal arterial ischemic stroke to the LH areas ordinarily subserving sentence processing. We compared them with their healthy age-matched siblings. All participants were tested on a battery of behavioral and functional imaging tasks. While stroke participants were impaired in some nonlinguistic cognitive abilities, their processing of sentences and of vocal emotion was normal and equal to that of their healthy siblings. In almost all, these abilities have both developed in the healthy RH. Our results provide insights into the remarkable ability of the young brain to reorganize language. Reorganization is highly constrained, with sentence processing almost always in the RH frontotemporal regions homotopic to their location in the healthy brain. This activation is somewhat segregated from RH emotion processing, suggesting that the two functions perform best when each has its own neural territory.
- Published
- 2022
- Full Text
- View/download PDF
29. Bioactive Phenolic Compounds from Peperomia obtusifolia .
- Author
-
Ware I, Franke K, Hussain H, Morgan I, Rennert R, and Wessjohann LA
- Subjects
- Anti-Bacterial Agents pharmacology, Antifungal Agents pharmacology, Humans, Phenols analysis, Plant Extracts chemistry, Plant Leaves chemistry, Peperomia chemistry
- Abstract
Peperomia obtusifolia (L.) A. Dietr., native to Middle America, is an ornamental plant also traditionally used for its mild antimicrobial properties. Chemical investigation on the leaves of P. obtusifolia resulted in the isolation of two previously undescribed compounds, named peperomic ester ( 1 ) and peperoside ( 2 ), together with five known compounds, viz. N -[2-(3,4-dihydroxyphenyl)ethyl]-3,4-dihydroxybenzamide ( 3 ), becatamide ( 4 ), peperobtusin A ( 5 ), peperomin B ( 6 ), and arabinothalictoside ( 7 ). The structures of these compounds were elucidated by 1D and 2D NMR techniques and HREIMS analyses. Compounds 1 - 7 were evaluated for their anthelmintic (against Caenorhabditis elegans ), antifungal (against Botrytis cinerea, Septoria tritici and Phytophthora infestans ), antibacterial (against Bacillus subtilis and Aliivibrio fischeri ), and antiproliferative (against PC-3 and HT-29 human cancer cell lines) activities. The known peperobtusin A ( 5 ) was the most active compound against the PC-3 cancer cell line with IC
50 values of 25.6 µM and 36.0 µM in MTT and CV assays, respectively. This compound also induced 90% inhibition of bacterial growth of the Gram-positive B. subtilis at a concentration of 100 µM. In addition, compound 3 showed anti-oomycotic activity against P. infestans with an inhibition value of 56% by using a concentration of 125 µM. However, no anthelmintic activity was observed.- Published
- 2022
- Full Text
- View/download PDF
30. Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouz.: Natural Fungal Compounds and Synthetic Derivatives with In Vitro Anthelmintic Activities and Antiproliferative Effects against Two Human Cancer Cell Lines.
- Author
-
Dube M, Llanes D, Saoud M, Rennert R, Imming P, Häberli C, Keiser J, and Arnold N
- Subjects
- Adult, Animals, Basidiomycota, Caenorhabditis elegans, Cell Line, Humans, Male, Adenocarcinoma drug therapy, Anthelmintics, Colorectal Neoplasms drug therapy
- Abstract
Neglected tropical diseases affect the world's poorest populations with soil-transmitted helminthiasis and schistosomiasis being among the most prevalent ones. Mass drug administration is currently the most important control measure, but the use of the few available drugs is giving rise to increased resistance of the parasites to the drugs. Different approaches are needed to come up with new therapeutic agents against these helminths. Fungi are a source of secondary metabolites, but most fungi remain largely uninvestigated as anthelmintics. In this report, the anthelmintic activity of Albatrellus confluens against Caenorhabditis elegans was investigated using bio-assay guided isolation. Grifolin ( 1 ) and neogrifolin ( 2 ) were identified as responsible for the anthelmintic activity. Derivatives 4 - 6 were synthesized to investigate the effect of varying the prenyl chain length on anthelmintic activity. The isolated compounds 1 and 2 and synthetic derivatives 4 - 6 , as well as their educts 7-10, were tested against Schistosoma mansoni (adult and newly transformed schistosomula), Strongyloides ratti , Heligmosomoides polygyrus , Necator americanus, and Ancylostoma ceylanicum. Prenyl-2-orcinol ( 4 ) and geranylgeranyl-2-orcinol ( 6 ) showed promising activity against newly transformed schistosomula. The compounds 1 , 2 , 4 , 5, and 6 were also screened for antiproliferative or cytotoxic activity against two human cancer lines, viz. prostate adenocarcinoma cells (PC-3) and colorectal adenocarcinoma cells (HT-29). Compound 6 was determined to be the most effective against both cell lines with IC
50 values of 16.1 µM in PC-3 prostate cells and 33.7 µM in HT-29 colorectal cells.- Published
- 2022
- Full Text
- View/download PDF
31. Surgical Outcomes Following Vestibular Schwannoma Resection in Patients over the Age of Sixty-five.
- Author
-
Strickland BA, Rennert R, Zada G, Shahrestani S, Russin JJ, Friedman RA, and Giannotta SL
- Abstract
Objective Vestibular schwannoma (VS) are benign, often slow growing neoplasms. Some institutions opt for radiosurgery in symptomatic patients of advanced age versus surgical resection. The aim of the study is to analyze surgical outcomes of VS in patients over the age of 65 who were either not candidates for or refused radiosurgery. Methods This includes retrospective analysis of VS patients between 1988 and 2020. Demographics, tumor characteristics, surgical records, and clinical outcomes were recorded. Patient preference for surgery over radiosurgery was recorded in the event that patients were offered both. Facial nerve outcomes were quantified using House-Brackmann (HB) scores. Tumor growth was defined by increase in size of >2 mm. Results In total, 64 patients were included of average age 72.4 years (65-84 years). Average maximum tumor diameter was 29 mm (13-55 mm). Forty-five patients were offered surgery or GKRS, and chose surgery commonly due to radiation aversion (48.4%). Gross total resection was achieved in 39.1% ( n = 25), near total 32.8% ( n = 21), and subtotal 28.1% ( n = 18). Average hospitalization was 5 days [2-17] with 75% ( n = 48) discharged home. Postoperative HB scores were good (HB1-2) in 43.8%, moderate (HB3-4) in 32.8%, and poor (HB5-6) in 23.4%. HB scores improved to good in 51.6%, moderate in 31.3%, and remained poor in 17.1%, marking a rate of facial nerve improvement of 10.9%. Tumor control was achieved in 95.3% of cases at an average follow-up time of 37.8 months. Conclusion VS resection can be safely performed in patients over the age of 65. Advanced age should not preclude a symptomatic VS patient from being considered for surgical resection., Competing Interests: Conflict of Interest None declared., (Thieme. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
32. Anthelmintic Activity and Cytotoxic Effects of Compounds Isolated from the Fruits of Ozoroa insignis Del. (Anacardiaceae).
- Author
-
Dube M, Saoud M, Rennert R, Fotso GW, Andrae-Marobela K, Imming P, Häberli C, Keiser J, and Arnold N
- Subjects
- Ancylostoma drug effects, Ancylostoma growth & development, Animals, Anthelmintics chemistry, Anthelmintics pharmacology, Antineoplastic Agents, Phytogenic chemistry, Antineoplastic Agents, Phytogenic pharmacology, Caenorhabditis elegans drug effects, Cell Proliferation drug effects, Cell Survival drug effects, Fruit chemistry, HT29 Cells, Humans, Magnetic Resonance Spectroscopy, Mass Spectrometry, Necator americanus drug effects, Necator americanus growth & development, Nematospiroides dubius drug effects, Nematospiroides dubius growth & development, PC-3 Cells, Plant Extracts chemistry, Plant Extracts pharmacology, Schistosoma mansoni drug effects, Schistosoma mansoni growth & development, Strongyloides ratti drug effects, Strongyloides ratti growth & development, Anacardiaceae chemistry, Anthelmintics isolation & purification, Antineoplastic Agents, Phytogenic isolation & purification, Caenorhabditis elegans growth & development, Plant Extracts isolation & purification
- Abstract
Ozoroa insignis Del. is an ethnobotanical plant widely used in traditional medicine for various ailments, including schistosomiasis, tapeworm, and hookworm infections. From the so far not investigated fruits of Ozoroa insignis , the anthelmintic principles could be isolated through bioassay-guided isolation using Caenorhabditis elegans and identified by NMR spectroscopic analysis and mass spectrometric studies. Isolated 6-[8( Z )-pentadecenyl] anacardic ( 1 ), 6-[10( Z )-heptadecenyl] anacardic acid ( 2 ), and 3-[7( Z )-pentadecenyl] phenol ( 3 ) were evaluated against the 5 parasitic organisms Schistosoma mansoni (adult and newly transformed schistosomula), Strongyloides ratti , Heligmosomoides polygyrus , Necator americanus , and Ancylostoma ceylanicum , which mainly infect humans and other mammals. Compounds 1 - 3 showed good activity against Schistosoma mansoni , with compound 1 showing the best activity against newly transformed schistosomula with 50% activity at 1µM. The isolated compounds were also evaluated for their cytotoxic properties against PC-3 (human prostate adenocarcinoma) and HT-29 (human colorectal adenocarcinoma) cell lines, whereby compounds 2 and 3 showed antiproliferative activity in both cancer cell lines, while compound 1 exhibited antiproliferative activity only on PC-3 cells. With an IC
50 value of 43.2 µM, compound 3 was found to be the most active of the 3 investigated compounds.- Published
- 2021
- Full Text
- View/download PDF
33. Rare Glutamic Acid Methyl Ester Peptaibols from Sepedonium ampullosporum Damon KSH 534 Exhibit Promising Antifungal and Anticancer Activity.
- Author
-
Lam YTH, Ricardo MG, Rennert R, Frolov A, Porzel A, Brandt W, Stark P, Westermann B, and Arnold N
- Subjects
- Ascomycota drug effects, Botrytis drug effects, Humans, Neoplasms pathology, Peptaibols chemistry, Phytophthora infestans drug effects, Tumor Cells, Cultured, Antifungal Agents pharmacology, Antineoplastic Agents pharmacology, Esters chemistry, Glutamic Acid chemistry, Hypocreales physiology, Neoplasms drug therapy, Peptaibols pharmacology
- Abstract
Fungal species of genus Sepedonium are rich sources of diverse secondary metabolites (e.g., alkaloids, peptaibols), which exhibit variable biological activities. Herein, two new peptaibols, named ampullosporin F ( 1 ) and ampullosporin G ( 2 ), together with five known compounds, ampullosporin A ( 3 ), peptaibolin ( 4 ), chrysosporide ( 5 ), c(Trp-Ser) ( 6 ) and c(Trp-Ala) ( 7 ), have been isolated from the culture of Sepedonium ampullosporum Damon strain KSH534. The structures of 1 and 2 were elucidated based on ESI-HRMS
n experiments and intense 1D and 2D NMR analyses. The sequence of ampullosporin F ( 1 ) was determined to be Ac-Trp1 -Ala2 -Aib3 -Aib4 -Leu5 -Aib6 -Gln7 -Aib8 -Aib9 -Aib10 -GluOMe11 -Leu12 -Aib13 -Gln14 -Leuol15 , while ampullosporin G ( 2 ) differs from 1 by exchanging the position of Gln7 with GluOMe11 . Furthermore, the total synthesis of 1 and 2 was carried out on solid-phase to confirm the absolute configuration of all chiral amino acids as L. In addition, ampullosporin F ( 1 ) and G ( 2 ) showed significant antifungal activity against B. cinerea and P. infestans , but were inactive against S. tritici . Cell viability assays using human prostate (PC-3) and colorectal (HT-29) cancer cells confirmed potent anticancer activities of 1 and 2 . Furthermore, a molecular docking study was performed in silico as an attempt to explain the structure-activity correlation of the characteristic ampullosporins ( 1 - 3 ).- Published
- 2021
- Full Text
- View/download PDF
34. First-in-Human Clinical Experience Using High-Definition Exoscope with Intraoperative Indocyanine Green for Clip Reconstruction of Unruptured Large Pediatric Aneurysm.
- Author
-
Wali AR, Kang KM, Rennert R, Santiago-Dieppa D, Khalessi AA, and Levy M
- Subjects
- Alagille Syndrome complications, Alagille Syndrome diagnostic imaging, Alagille Syndrome surgery, Child, Humans, Intracranial Aneurysm etiology, Intraoperative Neurophysiological Monitoring instrumentation, Male, Microsurgery instrumentation, Microsurgery methods, Neuroendoscopy instrumentation, Neuroendoscopy methods, Plastic Surgery Procedures instrumentation, Indocyanine Green administration & dosage, Intracranial Aneurysm diagnostic imaging, Intracranial Aneurysm surgery, Intraoperative Neurophysiological Monitoring methods, Plastic Surgery Procedures methods, Surgical Instruments
- Abstract
The operative exoscope is a novel tool that combines the benefits of surgical microscopes and endoscopes to yield excellent magnification and illumination while maintaining a comparatively small footprint and superior ergonomic features. Until recently, current exoscopes have been limited by 2-dimensional viewing; however, recently a 3-dimensional (3D), high-definition (4K-HD) exoscope has been developed (Sony-Olympus, Tokyo, Japan).
1 Our group had previously described the first in-human experiences with this novel tool including microsurgical clipping of intracranial aneurysms. We have highlighted the benefits of the exoscope, which include providing an immersive experience for surgeons and trainees, as well as superior ergonomics as compared with traditional microsurgery.2 To date, exoscopic 3D high-definition indocyanine green (ICG) video angiography (ICG-VA) has not been described. ICG-VA, now a mainstay of vascular microsurgery, uses intravenously injected dye to visualize intravascular fluorescence in real time to assess the patency of arteries and assess clip occlusion of aneurysms.3 , 4 The ability to safely couple this tool with the novel exoscope has the potential to advance cerebrovascular microsurgery. Here, we present a case of a 11-year-old male with Alagille syndrome, pancytopenia, and peripheral pulmonary stenosis found to have a 12 × 13 × 7 mm distal left M1 aneurysm arising from the inferior M1/M2 junction. The patient was neurologically intact without evidence of rupture. In order to prevent catastrophic rupture, the decision was made to treat the lesion. Due to the patients underlying medical conditions including baseline coagulopathy, surgical management was felt to be superior to an endovascular reconstruction, which would require long-term antiplatelet therapy. Thus the patient underwent a left-sided pterional craniotomy with exoscopic 3D ICG-VA. As demonstrated in Video 1, ICG-VA was performed before definitive clip placement in order to understand flow dynamics with particular emphasis on understanding the middle cerebral artery outflow. Postoperatively, the patient remained at his neurologic baseline and subsequent imaging demonstrated complete obliteration of the aneurysm without any neck remnant. The patient continues to follow and remains asymptomatic and neurologically intact without radiographic evidence of residual or recurrence., (Copyright © 2021 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
35. Bruceadysentoside A, a new pregnane glycoside and others secondary metabolites with cytotoxic activity from brucea antidysenterica J. F. Mill. (simaroubaceae).
- Author
-
Makong YS, Fotso GW, Mouthe GH, Lenta B, Rennert R, Sewald N, Arnold N, Wansi JD, and Ngadjui BT
- Subjects
- Brucea chemistry, Drug Screening Assays, Antitumor, Glycosides chemistry, HT29 Cells, Humans, Magnetic Resonance Spectroscopy, Molecular Structure, PC-3 Cells, Plant Extracts chemistry, Plant Leaves chemistry, Pregnanes chemistry, Secondary Metabolism, Spectrometry, Mass, Electrospray Ionization, Antineoplastic Agents, Phytogenic chemistry, Antineoplastic Agents, Phytogenic pharmacology, Brucea metabolism
- Abstract
The chemical investigation of the root barks leaves and stem barks of Brucea antidysenterica J. F. Mill. (Simaroubaceae) led to the isolation of a new pregnane glycoside, named Bruceadysentoside A or 3-O-β-L-arabinopyranosyl-pregn-5-en-20-one (1) together with seventeen known compounds. Their structures were established from spectral data, mainly HRESIMS, 1 D and 2 D NMR and by comparison with literature data. Compounds 1, 2, 5, 6, 8, 10, 12 and 13 were tested in vitro for their effects on the viability of two different human cancer cell lines, namely prostate PC-3 adenocarcinoma cells and colorectal HT-29 adenocarcinoma cells. No substantial activities were recorded for 2, 10, 12 and 13 (up to 10 μM concentration). 1, 5 and 8 did not show strong anti-proliferative effects up to 100 μM, however, 6 exhibited a stronger anti-proliferative effect with IC50 values of ∼ 100 μM against PC-3 and ∼ 200 μM against HT-29.
- Published
- 2021
- Full Text
- View/download PDF
36. Cichorins D-F: Three New Compounds from Cichorium intybus and Their Biological Effects.
- Author
-
Khan MF, Nasr FA, Noman OM, Alyhya NA, Ali I, Saoud M, Rennert R, Dube M, Hussain W, Green IR, Basudan OAM, Ullah R, Anazi SH, and Hussain H
- Subjects
- Anthelmintics, Anthraquinones isolation & purification, Cell Line, Tumor, Cell Survival drug effects, Humans, Inhibitory Concentration 50, Magnetic Resonance Spectroscopy, Medicine, Traditional, Molecular Structure, Naphthalenes chemistry, Sterols isolation & purification, Anthraquinones pharmacology, Cichorium intybus chemistry, Plant Extracts chemistry, Sterols pharmacology
- Abstract
Cichorium intybus L., (chicory) is employed in various traditional medicines to treat a wide range of diseases and disorders. In the current investigation, two new naphthalane derivatives viz., cichorins D ( 1 ) and E ( 2 ), along with one new anthraquinone cichorin F ( 3 ), were isolated from Cichorium intybus. In addition, three previously reported compounds viz., β-sitosterol ( 4 ), β-sitosterol β-glucopyranoside ( 5 ), and stigmasterol ( 6 ) were also isolated from Cichorium intybus. Their structures were established via extensive spectroscopic data, including 1D (
1 H and13 C) and 2D NMR (COSY, HSQC and HMBC), and ESIMS. Cichorin E ( 2 ) has a weak cytotoxic effect on breast cancer cells (MDA-MB-468: IC50 : 85.9 µM) and Ewing's sarcoma cells (SK-N-MC: IC50 : 71.1 µM); cichorin F ( 3 ) also illustrated weak cytotoxic effects on breast cancer cells (MDA-MB-468: IC50 : 41.0 µM and MDA-MB-231: IC50 : 45.6 µM), and SK-N-MC cells (IC50 : 71.9 µM). Moreover compounds 1 - 3 did not show any promising anthelmintic effects.- Published
- 2020
- Full Text
- View/download PDF
37. Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cells.
- Author
-
Kufka R, Rennert R, Kaluđerović GN, Weber L, Richter W, and Wessjohann LA
- Abstract
Tubugi-1 is a small cytotoxic peptide with picomolar cytotoxicity. To improve its cancer cell targeting, it was conjugated using a universal, modular disulfide derivative. This allowed conjugation to a neuropeptide-Y (NPY)-inspired peptide [K
4 (C-βA-),F7 ,L17 ,P34 ]-hNPY, acting as NPY Y1 receptor (hY1R)-targeting peptide, to form a tubugi-1-SS-NPY disulfide-linked conjugate. The cytotoxic impacts of the novel tubugi-1-NPY peptide-toxin conjugate, as well as of free tubugi-1, and tubugi-1 bearing the thiol spacer (liberated from tubugi-1-NPY conjugate), and native tubulysin A as reference were investigated by in vitro cell viability and proliferation screenings. The tumor cell lines HT-29, Colo320 (both colon cancer), PC-3 (prostate cancer), and in conjunction with RT-qPCR analyses of the hY1R expression, the cell lines SK-N-MC (Ewing`s sarcoma), MDA-MB-468, MDA-MB-231 (both breast cancer) and 184B5 (normal breast; chemically transformed) were investigated. As hoped, the toxicity of tubugi-1 was masked, with IC50 values decreased by ca. 1,000-fold compared to the free toxin. Due to intracellular linker cleavage, the cytotoxic potency of the liberated tubugi-1 that, however, still bears the thiol spacer (tubugi-1-SH) was restored and up to 10-fold higher compared to the entire peptide-toxin conjugate. The conjugate shows toxic selectivity to tumor cell lines overexpressing the hY1R receptor subtype like, e.g., the hard to treat triple-negative breast cancer MDA-MB-468 cells.- Published
- 2019
- Full Text
- View/download PDF
38. Multiple Intracranial Aneurysms from Coccidioidal Meningitis: Case Report Featuring Aneurysm Formation and Spontaneous Thrombosis with Literature Review.
- Author
-
Buchanan IA, Ravina K, Strickland B, Fredrickson V, She R, Mathew A, Rennert R, and Russin JJ
- Subjects
- Adult, Aneurysm, Infected diagnostic imaging, Aneurysm, Infected pathology, Aneurysm, Infected surgery, Aneurysm, Ruptured diagnostic imaging, Aneurysm, Ruptured pathology, Aneurysm, Ruptured surgery, Coccidioidomycosis diagnostic imaging, Coccidioidomycosis pathology, Coccidioidomycosis surgery, Humans, Intracranial Aneurysm diagnostic imaging, Intracranial Aneurysm pathology, Intracranial Aneurysm surgery, Male, Meningitis, Fungal diagnostic imaging, Meningitis, Fungal pathology, Meningitis, Fungal surgery, Subarachnoid Hemorrhage diagnostic imaging, Subarachnoid Hemorrhage etiology, Subarachnoid Hemorrhage pathology, Subarachnoid Hemorrhage surgery, Thrombosis diagnostic imaging, Thrombosis pathology, Thrombosis surgery, Aneurysm, Infected etiology, Aneurysm, Ruptured etiology, Coccidioidomycosis complications, Intracranial Aneurysm etiology, Meningitis, Fungal complications, Thrombosis etiology
- Abstract
Background: Coccidioidal meningitis can progress to vasculitis with aneurysm formation. Although aneurysmogenesis is rare, it carries exceptionally high mortality. Except in one instance, prior case reports have documented universally fatal consequences., Case Description: A 26-year-old man developed disseminated coccidioidomycosis with formation of multiple aneurysms throughout the anterior intracranial vasculature bilaterally. This report is unique in that it chronicles the formation and subsequent spontaneous thrombosis of several aneurysms over a 4-week period. In total 10 aneurysms were documented in the same patient-the highest reported to date. The patient was eventually discharged from the hospital for what has heretofore been a universally fatal disease process. Neurologic examination and vascular imaging 1 month after discharge demonstrated stable findings., Conclusions: Coccidioidal aneurysms carry a high mortality. The mainstay of therapy remains lifelong triazole antifungal therapy with the addition of liposomal amphotericin in cases of treatment failure. Steroid use is controversial but should be considered whenever there is vascular involvement. Although watchful waiting is reasonable in light of the possibility of spontaneous thrombosis with medical management, dynamic changes in aneurysm size or configuration should prompt timely endovascular or operative interventions., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
39. Vertebroplasty for vertebral compression fractures: Placebo or effective?
- Author
-
Wali AR, Martin JR, Rennert R, Resnick DK, Taylor W, Warnke P, and Chen CC
- Abstract
Vertebral compression fractures (VCFs) are a major cause of pain and disability. Here, we reviewed six randomized control trials (RCTs) focusing on the efficacy vs. placebo effect of vertebroplasty (VP) for symptomatic VCF. Four RCTs involved a nonsurgically treated control group. Two RCTs compared the use of VP vs. a sham surgery control group. Notably, RCTs comparing nonsurgically treated patients as a control group vs. those undergoing VP uniformly reported that VP contributed to improved pain relief. In contrast, RCTs comparing sham surgery vs. VP uniformly reported no significant differences between the two groups.
- Published
- 2017
- Full Text
- View/download PDF
40. Enrichment of Adipose-Derived Stromal Cells for BMPR1A Facilitates Enhanced Adipogenesis.
- Author
-
Zielins ER, Paik K, Ransom RC, Brett EA, Blackshear CP, Luan A, Walmsley GG, Atashroo DA, Senarath-Yapa K, Momeni A, Rennert R, Sorkin M, Seo EY, Chan CK, Gurtner GC, Longaker MT, and Wan DC
- Subjects
- Adipocytes cytology, Adipose Tissue cytology, Adult, Animals, Bone Morphogenetic Protein Receptors, Type I genetics, Cells, Cultured, Female, Humans, Lentivirus, Mice, Middle Aged, Stromal Cells cytology, Stromal Cells metabolism, Transduction, Genetic, Adipocytes metabolism, Adipogenesis, Adipose Tissue metabolism, Bone Morphogenetic Protein Receptors, Type I biosynthesis
- Abstract
Background: Reconstruction of soft tissue defects has traditionally relied on the use of grafts and flaps, which may be associated with variable resorption and/or significant donor site morbidity. Cell-based strategies employing adipose-derived stromal cells (ASCs), found within the stromal vascular fraction (SVF) of adipose tissue, may offer an alternative strategy for soft tissue reconstruction. In this study, we investigated the potential of a bone morphogenetic protein receptor type 1A (BMPR1A)(+) subpopulation of ASCs to enhance de novo adipogenesis., Methods: Human lipoaspirate was enzymatically digested to isolate SVF and magnetic-activated cell separation was utilized to obtain BMPR1A(+) and BMPR1A(-) cells. These cells, along with unenriched cells, were expanded in culture and evaluated for adipogenic gene expression and in vitro adipocyte formation. Cells from each group were also labeled with a green fluorescent protein (GFP) lentivirus and transplanted into the inguinal fat pads, an adipogenic niche, of immunocompromised mice to determine their potential for de novo adipogenesis. Confocal microscopy along with staining of lipid droplets and vasculature was performed to evaluate the formation of mature adipocytes by transplanted cells., Results: In comparison to BMPR1A(-) and unenriched ASCs, BMPR1A(+) cells demonstrated significantly enhanced adipogenesis when cultured in an adipogenic differentiation medium, as evidenced by increased staining with Oil Red O and increased expression of peroxisome proliferator-activating receptor gamma (PPAR-γ) and fatty acid-binding protein 4 (FABP4). BMPR1A(+) cells also formed significantly more adipocytes in vivo, as demonstrated by quantification of GFP+ adipocytes. Minimal formation of mature adipocytes was appreciated by BMPR1A(-) cells., Conclusions: BMPR1A(+) ASCs show an enhanced ability for adipogenesis in vitro, as shown by gene expression and histological staining. Furthermore, within an adipogenic niche, BMPR1A(+) cells possessed an increased capacity to generate de novo fat compared to BMPR1A(-) and unenriched cells. This suggests utility for the BMPR1A(+) subpopulation in cell-based strategies for soft tissue reconstruction.
- Published
- 2016
- Full Text
- View/download PDF
41. A cleavable cytolysin-neuropeptide Y bioconjugate enables specific drug delivery and demonstrates intracellular mode of action.
- Author
-
Ahrens VM, Kostelnik KB, Rennert R, Böhme D, Kalkhof S, Kosel D, Weber L, von Bergen M, and Beck-Sickinger AG
- Subjects
- Animals, COS Cells, Cell Line, Tumor, Cell Survival drug effects, Chlorocebus aethiops, Disulfides chemistry, HEK293 Cells, Humans, Receptors, Neuropeptide Y genetics, Drug Delivery Systems, Neuropeptide Y administration & dosage, Neuropeptide Y chemistry, Neuropeptide Y pharmacology, Perforin administration & dosage, Perforin chemistry, Perforin pharmacology, Receptors, Neuropeptide Y metabolism
- Abstract
Myxobacterial tubulysins are promising chemotherapeutics inhibiting microtubule polymerization, however, high unspecific toxicity so far prevents their application in therapy. For selective cancer cell targeting, here the coupling of a synthetic cytolysin to the hY1-receptor preferring peptide [F(7),P(34)]-neuropeptide Y (NPY) using a labile disulfide linker is described. Since hY1-receptors are overexpressed in breast tumors and internalize rapidly, this system has high potential as peptide-drug shuttle system. Molecular characterization of the cytolysin-[F(7),P(34)]-NPY bioconjugate revealed potent receptor activation and receptor-selective internalization, while viability studies verified toxicity. Triple SILAC studies comparing free cytolysin with the bioconjugate demonstrated an intracellular mechanism of action regardless of the delivery pathway. Treatments resulted in a regulation of proteins implemented in cell cycle arrest confirming the tubulysin-like effect of the cytolysin. Thus, the cytolysin-peptide bioconjugate fused by a cleavable linker enables a receptor-specific delivery as well as a potent intracellular drug-release with high cytotoxic activity., (Copyright © 2015. Published by Elsevier B.V.)
- Published
- 2015
- Full Text
- View/download PDF
42. Loss of keratinocyte focal adhesion kinase stimulates dermal proteolysis through upregulation of MMP9 in wound healing.
- Author
-
Wong VW, Garg RK, Sorkin M, Rustad KC, Akaishi S, Levi K, Nelson ER, Tran M, Rennert R, Liu W, Longaker MT, Dauskardt RH, and Gurtner GC
- Subjects
- Animals, Cells, Cultured, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Focal Adhesion Protein-Tyrosine Kinases biosynthesis, Humans, Immunoblotting, Immunohistochemistry, In Situ Hybridization, Infant, Newborn, Keratinocytes metabolism, Mice, Mice, Knockout, Microscopy, Electron, Transmission, Proteolysis, Wounds and Injuries metabolism, Wounds and Injuries pathology, Focal Adhesion Protein-Tyrosine Kinases genetics, Keratinocytes ultrastructure, RNA genetics, Skin injuries, Up-Regulation, Wound Healing, Wounds and Injuries genetics
- Abstract
Objective: To investigate how epithelial mechanotransduction pathways impact wound repair., Background: Mechanical forces are increasingly recognized to influence tissue repair, but their role in chronic wound pathophysiology remains unknown. Studies have shown that chronic wounds exhibit high levels of matrix metalloproteinase 9 (MMP9), a key proteolytic enzyme that regulates wound remodeling. We hypothesized that epithelial mechanosensory pathways regulated by keratinocyte-specific focal adhesion kinase (FAK) control dermal remodeling via MMP9., Methods: A standard wound model was applied to keratinocyte-specific FAK knockout (KO) and control mice. Rates of wound healing were measured and tissue was obtained for histologic and molecular analyses. Transcriptional and immunoblot assays were used to assess the activation of FAK, intracellular kinases, and MMP9 in vitro. A cell suspension model was designed to validate the importance of FAK mechanosensing, p38, and MMP9 secretion in human cells. Biomechanical testing was utilized to evaluate matrix tensile properties in FAK KO and control wounds., Results: Wound healing in FAK KO mice was significantly delayed compared with controls (closure at 15 days compared with 20 days, P = 0.0003). FAK KO wounds demonstrated decreased dermal thickness and collagen density. FAK KO keratinocytes exhibited overactive p38 and MMP9 signaling in vitro, findings recapitulated in human keratinocytes via the deactivation of FAK in the cell suspension model. Functionally, FAK KO wounds were significantly weaker and more brittle than control wounds, results consistent with the histologic and molecular analyses., Conclusions: Keratinocyte FAK is highly responsive to mechanical cues and may play a critical role in matrix remodeling via regulation of p38 and MMP9. These findings suggest that aberrant epithelial mechanosensory pathways may contribute to pathologic dermal proteolysis and wound chronicity.
- Published
- 2014
- Full Text
- View/download PDF
43. Positive selection for bone morphogenetic protein receptor type-IB promotes differentiation and specification of human adipose-derived stromal cells toward an osteogenic lineage.
- Author
-
McArdle A, Chung MT, Paik KJ, Duldulao C, Chan C, Rennert R, Walmsley GG, Senarath-Yapa K, Hu M, Seo E, Lee M, Wan DC, and Longaker MT
- Subjects
- Adult, Cell Differentiation physiology, Cell Proliferation, Cells, Cultured, Female, Humans, Adipocytes cytology, Adipocytes physiology, Bone Morphogenetic Protein Receptors, Type I metabolism, Cell Separation methods, Osteogenesis physiology, Stem Cells cytology, Stem Cells physiology
- Abstract
Background: Adipose tissue represents an abundant and easily accessible source of multipotent cells that may serve as an excellent building block for tissue engineering. However, adipose-derived stromal cells (ASCs) are a heterogeneous group and subpopulations may be identified with enhanced osteogenic potential., Methods: Human ASC subpopulations were prospectively isolated based on expression of bone morphogenetic protein receptor type-IB (BMPR-IB). Unsorted, BMPR-IB(+), and BMPR-IB(-) cells were analyzed for their osteogenic capacity through histological staining and gene expression. To evaluate their in vivo osteogenic potential, critical-sized calvarial defects were created in immunocompromised mice and treated with unsorted, BMPR-IB(+), or BMPR-IB(-) cells. Healing was assessed using microcomputed tomography and pentachrome staining of specimens at 8 weeks., Results: Increased osteogenic differentiation was noted in the BMPR-IB(+) subpopulation, as demonstrated by alkaline phosphatase staining at day 7 and extracellular matrix mineralization with Alizarin red staining at day 14. This was also associated with increased expression for osteocalcin, a late marker of osteogenesis. Radiographic analysis demonstrated significantly enhanced healing of critical-sized calvarial defects treated with BMPR-IB(+) ASCs compared with unsorted or BMPR-IB(-) cells. This was confirmed through pentachrome staining, which revealed more robust bone regeneration in the BMPR-IB(+) group., Conclusion: BMPR-IB(+) human ASCs have an enhanced ability to form bone both in vitro and in vivo. These data suggest that positive selection for BMPR-IB(+) and manipulation of the BMP pathway in these cells may yield a highly osteogenic subpopulation of cells for bone tissue engineering.
- Published
- 2014
- Full Text
- View/download PDF
44. Angiogenic properties of dehydrated human amnion/chorion allografts: therapeutic potential for soft tissue repair and regeneration.
- Author
-
Koob TJ, Lim JJ, Massee M, Zabek N, Rennert R, Gurtner G, and Li WW
- Abstract
Background: Chronic wounds are associated with a number of deficiencies in critical wound healing processes, including growth factor signaling and neovascularization. Human-derived placental tissues are rich in regenerative cytokines and have been shown in randomized clinical trials to be effective for healing chronic wounds. In this study, PURION® Processed (MiMedx Group, Marietta, GA) dehydrated human amnion/chorion membrane tissue allografts (dHACM, EpiFix®, MiMedx) were evaluated for properties to support wound angiogenesis., Methods: Angiogenic growth factors were identified in dHACM tissues using enzyme-linked immunosorbent assays (ELISAs), and the effects of dHACM extract on human microvascular endothelial cell (HMVEC) proliferation and production of angiogenic growth factors was determined in vitro. Chemotactic migration of human umbilical vein endothelial cells (HUVECs) toward pieces of dHACM tissue was determined using a standard in vitro transwell assay. Neovascularization of dHACM in vivo was determined utilizing a murine subcutaneous implant model., Results: Quantifiable levels of the angiogenic cytokines angiogenin, angiopoietin-2 (ANG-2), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), heparin binding epidermal growth factor (HB-EGF), hepatocyte growth factor (HGF), platelet derived growth factor BB (PDGF-BB), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) were measured in dHACM. Soluble cues promoted HMVEC proliferation in vitro and increased endogenous production of over 30 angiogenic factors by HMVECs, including granulocyte macrophage colony-stimulating factor (GM-CSF), angiogenin, transforming growth factor β3 (TGF-β3), and HB-EGF. 6.0 mm disks of dHACM tissue were also found to recruit migration of HUVECs in vitro. Moreover, subcutaneous dHACM implants displayed a steady increase in microvessels over a period of 4 weeks, indicative of a dynamic intra-implant neovascular process., Conclusions: TAKEN TOGETHER, THESE RESULTS DEMONSTRATE THAT DHACM GRAFTS: 1) contain angiogenic growth factors retaining biological activity; 2) promote amplification of angiogenic cues by inducing endothelial cell proliferation and migration and by upregulating production of endogenous angiogenic growth factors by endothelial cells; and 3) support the formation of blood vessels in vivo. dHACM grafts are a promising wound care therapy with the potential to promote revascularization and tissue healing within poorly vascularized, non-healing wounds.
- Published
- 2014
- Full Text
- View/download PDF
45. Abstract 151: short hairpin RNA interference therapy for diabetic murine wound closure and hindlimb ischemia.
- Author
-
Paik KJ, Rennert R, Chung MT, Sorkin M, Duscher D, Atashroo D, Chen HH, Morrison SD, Zimmermann A, Nauta A, Ko SH, Tevlin R, Zielins E, Hu MS, McArdle A, Walmsley G, Senarath-Yapa K, Hong WX, Garza RM, Duldulao C, Wearda T, Momeni A, Wu JC, Gurtner GC, Longaker MT, and Wan DC
- Published
- 2014
- Full Text
- View/download PDF
46. Biological properties of dehydrated human amnion/chorion composite graft: implications for chronic wound healing.
- Author
-
Koob TJ, Rennert R, Zabek N, Massee M, Lim JJ, Temenoff JS, Li WW, and Gurtner G
- Subjects
- Amnion cytology, Animals, Cell Proliferation, Chorion cytology, Chronic Disease, Cytokines metabolism, Dehydration, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Humans, Mice, Wounds and Injuries metabolism, Wounds and Injuries pathology, Amnion transplantation, Chorion transplantation, Mesenchymal Stem Cells cytology, Stem Cell Transplantation methods, Tissue and Organ Procurement methods, Wound Healing physiology, Wounds and Injuries surgery
- Abstract
Human amnion/chorion tissue derived from the placenta is rich in cytokines and growth factors known to promote wound healing; however, preservation of the biological activities of therapeutic allografts during processing remains a challenge. In this study, PURION® (MiMedx, Marietta, GA) processed dehydrated human amnion/chorion tissue allografts (dHACM, EpiFix®, MiMedx) were evaluated for the presence of growth factors, interleukins (ILs) and tissue inhibitors of metalloproteinases (TIMPs). Enzyme-linked immunosorbent assays (ELISA) were performed on samples of dHACM and showed quantifiable levels of the following growth factors: platelet-derived growth factor-AA (PDGF-AA), PDGF-BB, transforming growth factor α (TGFα), TGFβ1, basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), placental growth factor (PLGF) and granulocyte colony-stimulating factor (GCSF). The ELISA assays also confirmed the presence of IL-4, 6, 8 and 10, and TIMP 1, 2 and 4. Moreover, the relative elution of growth factors into saline from the allograft ranged from 4% to 62%, indicating that there are bound and unbound fractions of these compounds within the allograft. dHACM retained biological activities that cause human dermal fibroblast proliferation and migration of human mesenchymal stem cells (MSCs) in vitro. An in vivo mouse model showed that dHACM when tested in a skin flap model caused mesenchymal progenitor cell recruitment to the site of implantation. The results from both the in vitro and in vivo experiments clearly established that dHACM contains one or more soluble factors capable of stimulating MSC migration and recruitment. In summary, PURION® processed dHACM retains its biological activities related to wound healing, including the potential to positively affect four distinct and pivotal physiological processes intimately involved in wound healing: cell proliferation, inflammation, metalloproteinase activity and recruitment of progenitor cells. This suggests a paracrine mechanism of action for dHACM when used for wound healing applications., (©2013 The Authors. International Wound Journal published by John Wiley & Sons Ltd and Medicalhelplines.com Inc.)
- Published
- 2013
- Full Text
- View/download PDF
47. Isolation of human adipose-derived stromal cells using laser-assisted liposuction and their therapeutic potential in regenerative medicine.
- Author
-
Chung MT, Zimmermann AS, Paik KJ, Morrison SD, Hyun JS, Lo DD, McArdle A, Montoro DT, Walmsley GG, Senarath-Yapa K, Sorkin M, Rennert R, Chen HH, Chung AS, Vistnes D, Gurtner GC, Longaker MT, and Wan DC
- Subjects
- Adipose Tissue metabolism, Animals, Cell Differentiation, Cell Proliferation, Cell Survival, Flow Cytometry, Humans, Lasers, Mice, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Stromal Cells metabolism, Adipose Tissue cytology, Lipectomy methods, Regenerative Medicine methods, Stromal Cells cytology, Tissue Engineering methods
- Abstract
Harvesting adipose-derived stromal cells (ASCs) for tissue engineering is frequently done through liposuction. However, several different techniques exist. Although third-generation ultrasound-assisted liposuction has been shown to not have a negative effect on ASCs, the impact of laser-assisted liposuction on the quality and differentiation potential of ASCs has not been studied. Therefore, ASCs were harvested from laser-assisted lipoaspirate and suction-assisted lipoaspirate. Next, in vitro parameters of cell yield, cell viability and proliferation, surface marker phenotype, osteogenic differentiation, and adipogenic differentiation were performed. Finally, in vivo bone formation was assessed using a critical-sized cranial defect in athymic nude mice. Although ASCs isolated from suction-assisted lipoaspirate and laser-assisted lipoaspirate both successfully underwent osteogenic and adipogenic differentiation, the cell yield, viability, proliferation, and frequency of ASCs (CD34(+)CD31(-)CD45(-)) in the stromal vascular fraction were all significantly less with laser-assisted liposuction in vitro (p < .05). In vivo, quantification of osseous healing by micro-computed tomography revealed significantly more healing with ASCs isolated from suction-assisted lipoaspirate relative to laser-assisted lipoaspirate at the 4-, 6-, and 8-week time points (p < .05). Therefore, as laser-assisted liposuction appears to negatively impact the biology of ASCs, cell harvest using suction-assisted liposuction is preferable for tissue-engineering purposes.
- Published
- 2013
- Full Text
- View/download PDF
48. CD90 (Thy-1)-positive selection enhances osteogenic capacity of human adipose-derived stromal cells.
- Author
-
Chung MT, Liu C, Hyun JS, Lo DD, Montoro DT, Hasegawa M, Li S, Sorkin M, Rennert R, Keeney M, Yang F, Quarto N, Longaker MT, and Wan DC
- Subjects
- Adult, Alkaline Phosphatase metabolism, Animals, Cell Differentiation, Cell Size, Female, Flow Cytometry, Gene Expression Regulation, Humans, Mice, Middle Aged, Skull pathology, Staining and Labeling, Stromal Cells cytology, Stromal Cells enzymology, Adipose Tissue cytology, Osteogenesis, Thy-1 Antigens metabolism
- Abstract
Background: Stem cell-based bone tissue engineering with adipose-derived stromal cells (ASCs) has shown great promise for revolutionizing treatment of large bone deficits. However, there is still a lack of consensus on cell surface markers identifying osteoprogenitors. Fluorescence-activated cell sorting has identified a subpopulation of CD105(low) cells with enhanced osteogenic differentiation. The purpose of the present study was to compare the ability of CD90 (Thy-1) to identify osteoprogenitors relative to CD(105)., Methods: Unsorted cells, CD90(+), CD90(-), CD105(high), and CD105(low) cells were treated with an osteogenic differentiation medium. For evaluation of in vitro osteogenesis, alkaline phosphatase (ALP) staining and alizarin red staining were performed at 7 days and 14 days, respectively. RNA was harvested after 7 and 14 days of differentiation, and osteogenic gene expression was examined by quantitative real-time polymerase chain reaction. For evaluation of in vivo osteogenesis, critical-sized (4-mm) calvarial defects in nude mice were treated with the hydroxyapatite-poly(lactic-co-glycolic acid) scaffold seeded with the above-mentioned subpopulations. Healing was followed using micro-CT scans for 8 weeks. Calvaria were harvested at 8 weeks postoperatively, and sections were stained with Movat's Pentachrome., Results: Transcriptional analysis revealed that the CD90(+) subpopulation was enriched for a more osteogenic subtype relative to the CD105(low) subpopulation. Staining at day 7 for ALP was greatest in the CD90(+) cells, followed by the CD105(low) cells. Staining at day 14 for alizarin red demonstrated the greatest amount of mineralized extracellular matrix in the CD90(+) cells, again followed by the CD105(low) cells. Quantification of in vivo healing at 2, 4, 6, and 8weeks postoperatively demonstrated increased bone formation in defects treated with CD90(+) ASCs relative to all other groups. On Movat's Pentachrome-stained sections, defects treated with CD90(+) cells showed the most robust bony regeneration. Defects treated with CD90(-) cells, CD105(high) cells, and CD105(low) cells demonstrated some bone formation, but to a lesser degree when compared with the CD90(+) group., Conclusions: While CD105(low) cells have previously been shown to possess an enhanced osteogenic potential, we found that CD90(+) cells are more capable of forming bone both in vitro and in vivo. These data therefore suggest that CD90 may be a more effective marker than CD105 to isolate a highly osteogenic subpopulation for bone tissue engineering.
- Published
- 2013
- Full Text
- View/download PDF
49. High cost of stage IV pressure ulcers.
- Author
-
Brem H, Maggi J, Nierman D, Rolnitzky L, Bell D, Rennert R, Golinko M, Yan A, Lyder C, and Vladeck B
- Subjects
- Humans, Pressure Ulcer diagnosis, Pressure Ulcer economics, Severity of Illness Index, United States, Cost of Illness, Hospital Costs, Hospitals, University economics, Length of Stay economics, Pressure Ulcer therapy
- Abstract
Background: The aim of this study was to calculate and analyze the cost of treatment for stage IV pressure ulcers., Methods: A retrospective chart analysis of patients with stage IV pressure ulcers was conducted. Hospital records and treatment outcomes of these patients were followed up for a maximum of 29 months and analyzed. Costs directly related to the treatment of pressure ulcers and their associated complications were calculated., Results: Nineteen patients with stage IV pressure ulcers (11 hospital-acquired and 8 community-acquired) were identified and their charts were reviewed. The average hospital treatment cost associated with stage IV pressure ulcers and related complications was $129,248 for hospital-acquired ulcers during 1 admission, and $124,327 for community-acquired ulcers over an average of 4 admissions., Conclusions: The costs incurred from stage IV pressure ulcers are much greater than previously estimated. Halting the progression of early stage pressure ulcers has the potential to eradicate enormous pain and suffering, save thousands of lives, and reduce health care expenditures by millions of dollars., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
50. Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity.
- Author
-
Neundorf I, Rennert R, Hoyer J, Schramm F, Löbner K, Kitanovic I, and Wölfl S
- Abstract
Cell-penetrating peptides (CPP) have become a widely used tool for efficient cargo delivery into cells. However, one limiting fact is their uptake by endocytosis causing the enclosure of the CPP-cargo construct within endosomes. One often used method to enhance the outflow into the cytosol is the fusion of endosome-disruptive peptide or protein sequences to CPP. But, until now, no studies exist investigating the effects of the fusion peptide to the cellular distribution, structural arrangements and cytotoxic behaviour of the CPP. In this study, we attached a short modified sequence of hemagglutinin subunit HA2 to different CPP and analysed the biologic activity of the new designed peptides. Interestingly, we observed an increased cytosolic distribution but also highly toxic activities in the micromolar range against several cell lines. Structural analysis revealed that attachment of the fusion peptide had profound implications on the whole conformation of the peptide, which might be responsible for membrane interaction and endosome disruption.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.